<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Endovascular revascularisation versus conservative management for intermittent claudication - Fakhry, F - 2018 | Cochrane Library</title> <meta content="Endovascular revascularisation versus conservative management for intermittent claudication - Fakhry, F - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010512.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Endovascular revascularisation versus conservative management for intermittent claudication - Fakhry, F - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010512.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010512.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Endovascular revascularisation versus conservative management for intermittent claudication" name="citation_title"/> <meta content="Farzin Fakhry" name="citation_author"/> <meta content="Erasmus MC" name="citation_author_institution"/> <meta content="farzin.fakhry@gmail.com" name="citation_author_email"/> <meta content="Hugo JP Fokkenrood" name="citation_author"/> <meta content="Rijnstate" name="citation_author_institution"/> <meta content="Sandra Spronk" name="citation_author"/> <meta content="Joep AW Teijink" name="citation_author"/> <meta content="Catharina Hospital" name="citation_author_institution"/> <meta content="Ellen V Rouwet" name="citation_author"/> <meta content="Erasmus MC" name="citation_author_institution"/> <meta content="M G Myriam Hunink" name="citation_author"/> <meta content="Erasmus MC" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD010512.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/03/08" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010512.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010512.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010512.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cilostazol; Combined Modality Therapy [methods]; Conservative Treatment [*methods]; Exercise Therapy; Intermittent Claudication [*therapy]; Randomized Controlled Trials as Topic; Tetrazoles [therapeutic use]; *Vascular Surgical Procedures; Vasodilator Agents [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010512.pub2&amp;doi=10.1002/14651858.CD010512.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010512\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010512\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010512.pub2",title:"Endovascular revascularisation versus conservative management for intermittent claudication",firstPublishedDate:"Mar 8, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010512.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010512.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010512.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010512.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010512.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010512.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010512.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010512.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010512.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010512.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3379 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010512.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-sec-0105"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-sec-0053"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-sec-0099"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/appendices#CD010512-sec-0110"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/table_n/CD010512StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/table_n/CD010512StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Endovascular revascularisation versus conservative management for intermittent claudication</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#CD010512-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Farzin Fakhry</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#CD010512-cr-0003">Hugo JP Fokkenrood</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#CD010512-cr-0004">Sandra Spronk</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#CD010512-cr-0005">Joep AW Teijink</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#CD010512-cr-0006">Ellen V Rouwet</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information#CD010512-cr-0007">M G Myriam Hunink</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information/en#CD010512-sec-0114">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 08 March 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010512.pub2">https://doi.org/10.1002/14651858.CD010512.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010512-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010512-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010512-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010512-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010512-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010512-abs-0001" lang="en"> <section id="CD010512-sec-0001"> <h3 class="title" id="CD010512-sec-0001">Background</h3> <p>Intermittent claudication (IC) is the classic symptomatic form of peripheral arterial disease affecting an estimated 4.5% of the general population aged 40 years and older. Patients with IC experience limitations in their ambulatory function resulting in functional disability and impaired quality of life (QoL). Endovascular revascularisation has been proposed as an effective treatment for patients with IC and is increasingly performed. </p> </section> <section id="CD010512-sec-0002"> <h3 class="title" id="CD010512-sec-0002">Objectives</h3> <p>The main objective of this systematic review is to summarise the (added) effects of endovascular revascularisation on functional performance and QoL in the management of IC. </p> </section> <section id="CD010512-sec-0003"> <h3 class="title" id="CD010512-sec-0003">Search methods</h3> <p>For this review the Cochrane Vascular Information Specialist (CIS) searched the Specialised Register (February 2017) and the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1). The CIS also searched trials registries for details of ongoing and unpublished studies. </p> </section> <section id="CD010512-sec-0004"> <h3 class="title" id="CD010512-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing endovascular revascularisation (± conservative therapy consisting of supervised exercise or pharmacotherapy) versus no therapy (except advice to exercise) or versus conservative therapy (i.e. supervised exercise or pharmacotherapy) for IC. </p> </section> <section id="CD010512-sec-0005"> <h3 class="title" id="CD010512-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected studies, extracted data, and assessed the methodological quality of studies. Given large variation in the intensity of treadmill protocols to assess walking distances and use of different instruments to assess QoL, we used standardised mean difference (SMD) as treatment effect for continuous outcome measures to allow standardisation of results and calculated the pooled SMD as treatment effect size in meta‐analyses. We interpreted pooled SMDs using rules of thumb (&lt; 0.40 = small, 0.40 to 0.70 = moderate, &gt; 0.70 = large effect) according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. We calculated the pooled treatment effect size for dichotomous outcome measures as odds ratio (OR). </p> </section> <section id="CD010512-sec-0006"> <h3 class="title" id="CD010512-sec-0006">Main results</h3> <p>We identified ten RCTs (1087 participants) assessing the value of endovascular revascularisation in the management of IC. These RCTs compared endovascular revascularisation versus no specific treatment for IC or conservative therapy or a combination therapy of endovascular revascularisation <i>plus</i> conservative therapy versus conservative therapy alone. In the included studies, conservative treatment consisted of supervised exercise or pharmacotherapy with cilostazol 100 mg twice daily. The quality of the evidence ranged from low to high and was downgraded mainly owing to substantial heterogeneity and small sample size. </p> <p>Comparing endovascular revascularisation versus no specific treatment for IC (except advice to exercise) showed a moderate effect on maximum walking distance (MWD) (SMD 0.70, 95% confidence interval (CI) 0.31 to 1.08; 3 studies; 125 participants; moderate‐quality evidence) and a large effect on pain‐free walking distance (PFWD) (SMD 1.29, 95% CI 0.90 to 1.68; 3 studies; 125 participants; moderate‐quality evidence) in favour of endovascular revascularisation. Long‐term follow‐up in two studies (103 participants) showed no clear differences between groups for MWD (SMD 0.67, 95% CI ‐0.30 to 1.63; low‐quality evidence) and PFWD (SMD 0.69, 95% CI ‐0.45 to 1.82; low‐quality evidence). The number of secondary invasive interventions (OR 0.81, 95% CI 0.12 to 5.28; 2 studies; 118 participants; moderate‐quality evidence) was also not different between groups. One study reported no differences in disease‐specific QoL after two years. </p> <p>Data from five studies (n = 345) comparing endovascular revascularisation versus supervised exercise showed no clear differences between groups for MWD (SMD ‐0.42, 95% CI ‐0.87 to 0.04; moderate‐quality evidence) and PFWD (SMD ‐0.05, 95% CI ‐0.38 to 0.29; moderate‐quality evidence). Similarliy, long‐term follow‐up in three studies (184 participants) revealed no differences between groups for MWD (SMD ‐0.02, 95% CI ‐0.36 to 0.32; moderate‐quality evidence) and PFWD (SMD 0.11, 95% CI ‐0.26 to 0.48; moderate‐quality evidence). In addition, high‐quality evidence showed no difference between groups in the number of secondary invasive interventions (OR 1.40, 95% CI 0.70 to 2.80; 4 studies; 395 participants) and in disease‐specific QoL (SMD 0.18, 95% CI ‐0.04 to 0.41; 3 studies; 301 participants). </p> <p>Comparing endovascular revascularisation <i>plus</i> supervised exercise versus supervised exercise alone showed no clear differences between groups for MWD (SMD 0.26, 95% CI ‐0.13 to 0.64; 3 studies; 432 participants; moderate‐quality evidence) and PFWD (SMD 0.33, 95% CI ‐0.26 to 0.93; 2 studies; 305 participants; moderate‐quality evidence). Long‐term follow‐up in one study (106 participants) revealed a large effect on MWD (SMD 1.18, 95% CI 0.65 to 1.70; low‐quality evidence) in favour of the combination therapy. Reports indicate that disease‐specific QoL was comparable between groups (SMD 0.25, 95% CI ‐0.05 to 0.56; 2 studies; 330 participants; moderate‐quality evidence) and that the number of secondary invasive interventions (OR 0.27, 95% CI 0.13 to 0.55; 3 studies; 457 participants; high‐quality evidence) was lower following combination therapy.<br/> <br/> Two studies comparing endovascular revascularisation <i>plus</i> pharmacotherapy (cilostazol) versus pharmacotherapy alone provided data showing a small effect on MWD (SMD 0.38, 95% CI 0.08 to 0.68; 186 participants; high‐quality evidence), a moderate effect on PFWD (SMD 0.63, 95% CI 0.33 to 0.94; 186 participants; high‐quality evidence), and a moderate effect on disease‐specific QoL (SMD 0.59, 95% CI 0.27 to 0.91; 170 participants; high‐quality evidence) in favour of combination therapy. Long‐term follow‐up in one study (47 participants) revealed a moderate effect on MWD (SMD 0.72, 95% CI 0.09 to 1.36; P = 0.02) in favour of combination therapy and no clear differences in PFWD between groups (SMD 0.54, 95% CI ‐0.08 to 1.17; P = 0.09). The number of secondary invasive interventions was comparable between groups (OR 1.83, 95% CI 0.49 to 6.83; 199 participants; high‐quality evidence). </p> </section> <section id="CD010512-sec-0007"> <h3 class="title" id="CD010512-sec-0007">Authors' conclusions</h3> <p>In the management of patients with IC, endovascular revascularisation does not provide significant benefits compared with supervised exercise alone in terms of improvement in functional performance or QoL. Although the number of studies is small and clinical heterogeneity underlines the need for more homogenous and larger studies, evidence suggests that a synergetic effect may occur when endovascular revascularisation is combined with a conservative therapy of supervised exercise or pharmacotherapy with cilostazol: the combination therapy seems to result in greater improvements in functional performance and in QoL scores than are seen with conservative therapy alone. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010512-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010512-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010512-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010512-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010512-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010512-abs-0005">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010512-abs-0004" lang="en"> <h3>Endovascular revascularisation for intermittent claudication (pain in the legs)</h3> <p><b>Background</b> </p> <p>Intermittent claudication, affecting approximately 4.5% of the general population aged 40 years and older, is a common symptomatic form of peripheral arterial disease and is characterised by pain in the calf or buttock in the legs that starts with walking and eases with rest. This leg pain is caused by reduced blood flow to leg muscles due to a blockage in the leg arteries as a consequence of atherosclerosis (hardening and plaque buildup in the arteries). People with intermittent claudication experience severely limited walking distances, resulting in a sedentary lifestyle and decreased quality of life. </p> <p>Peripheral endovascular revascularisation (angioplasty) is a minimally invasive procedure performed to clear blockages in the leg arteries that cause decreased blood flow. This procedure is widely used for people with intermittent claudication. In this review we searched the available literature (current until February 2017) to assess the effectiveness of endovascular revascularisation compared with no specific therapy for intermittent claudication, or compared with a conservative therapy option such as supervised exercise or drug therapy. </p> <p><b>Study characteristics and key results</b> </p> <p>Our search identified ten trials with a total of 1087 participants. Reviewers judged the overall methodological quality of these studies as moderate. </p> <p>Data from three studies comparing endovascular revascularisation with no specific treatment for intermittent claudication except advice to exercise showed a moderate to large effect on walking distances in favour of endovascular revascularisation in the short term. However after long‐term follow up in two studies, this short‐term advantage of endovascular revascularisation had disappeared. The number of additional surgical procedures was not different between groups. One study reported no differences in disease‐specific quality of life after two years. </p> <p>Data from five studies comparing endovascular revascularisation with supervised exercise for intermittent claudication showed both therapies to be more or less comparable in terms of improving walking distances, number of additional surgical procedures, and quality of life. </p> <p>Data from three studies comparing a combination therapy of endovascular revascularisation plus supervised exercise versus supervised exercise alone showed no clear differences between groups for walking distances in the short term, and data from one study showed a large effect on walking distances in favour of combination therapy over the long term. Disease‐specific quality of life was comparable between study groups. The number of additional surgical procedures was lower following combination therapy. </p> <p>Finally, when comparing a combination therapy of endovascular revascularisation plus drug therapy with cilostazol versus drug therapy alone, two studies provided data showing small to moderate effects on walking distance and on quality of life in favour of the combination therapy. The number of additional surgical procedures was comparable between study groups. </p> <p><b>Quality of the evidence</b> </p> <p>Overall, reviewers rated the quality of evidence for outcomes in the comparison of endovascular revascularisation versus no specific therapy for intermittent claudication as low to moderate mainly owing to small study sample sizes and the possibility of serious risk of bias in these studies. For comparisons of endovascular revascularisation versus conservative therapy, and the combination therapy of endovascular revascularisation and conservative therapy versus conservative therapy alone, reviewers generally rated the quality of evidence for outcomes as moderate to high mainly owing to substantial differences between studies. </p> <p><b>Conclusion</b> </p> <p>This review assessed results reported by a limited number of studies showing that endovascular revascularisation and supervised exercise are more or less comparable treatment options in improving walking distances and quality of life among individuals with intermittent claudication. Combination therapy (endovascular revascularisation with either supervised exercise or drug therapy (cilostazol)) seems to result in greater improvements in walking distance and in quality of life than are seen with supervised exercise or drug therapy alone. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010512-sec-0105" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010512-sec-0105"></div> <h3 class="title" id="CD010512-sec-0106">Implications for practice</h3> <section id="CD010512-sec-0106"> <p>In the management of patients with intermittent claudication, endovascular revascularisation does not provide significant benefits compared with supervised exercise therapy alone in terms of improvement in functional performance or quality of life. Although the number of studies is small with presence of some clinical heterogeneity, evidence suggests a possible synergetic effect when endovascular revascularisation is combined with a conservative therapy of supervised exercise or pharmacotherapy with cilostazol: the combination therapy seems to result in greater improvements in functional performance and quality of life scores when compared with conservative therapy alone. </p> </section> <h3 class="title" id="CD010512-sec-0107">Implications for research</h3> <section id="CD010512-sec-0107"> <p>More large (and long‐term) studies assessing the added effect of endovascular revascularisation over and above supervised exercise therapy, or assessing the effectiveness of a stepped care approach with supervised exercise followed by endovascular revascularisation if needed, are required to define the optimal treatment strategy for the growing population of patients with intermittent claudication. In addition, health economic analyses of these combined treatment strategies are scarce and are urgently needed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010512-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010512-sec-0022"></div> <div class="table" id="CD010512-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endovascular revascularisation compared with no specific therapy for intermittent claudication except verbal advice to exercise</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Endovascular revascularisation compared with no specific therapy for intermittent claudication except verbal advice to exercise </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> intermittent claudication<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> endovascular revascularisation<br/> <b>Comparison:</b> no specific therapy<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no specific therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endovascular revascularisation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.70 standard deviations higher (0.31 higher to 1.08 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximum walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean maximum walking distance at long term in the intervention group was 0.67 standard deviations higher (0.30 lower to 1.63 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 1.29 standard deviations higher (0.90 higher to 1.68 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean pain‐free walking distance at long term in the intervention group was 0.69 standard deviations higher (0.45 lower to 1.82 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.81<br/> (0.12 to 5.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>118<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>83 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>69 per 1000<br/> (11 to 324) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life (disease‐specific)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study reported no significant differences in disease‐specific QoL between study groups after 2 years without providing data </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). Pooled standardised mean differences were interpreted using rules of thumb (&lt; 0.40 = small, 0.40 to 0.70 = moderate, &gt; 0.70 = large effect) as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).<br/> CI: confidence interval; OR: odds ratio; QoL: quality of life; RCT: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Treatment consisted of cardiovascular risk factor management and only verbal exercise advice without any form of supervision.<br/> <sup>2</sup> In two studies, risk of bias on three or more domains judged as "unclear"; therefore quality of the evidence downgraded one level.<br/> <sup>3</sup> The possibility of publication bias could not be ruled out, yet we did not consider it sufficient to downgrade the quality of the evidence.<br/> <sup>4</sup> Small sample size with wide confidence interval for treatment effect; therefore quality of the evidence downgraded one level.<br/> <sup>5</sup> Evidence of inconsistency due to substantial heterogeneity between studies; therefore quality of the evidence downgraded one level. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010512-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Endovascular revascularisation compared with conservative therapy for intermittent claudication</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Endovascular revascularisation compared with conservative therapy for intermittent claudication </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> intermittent claudication<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> endovascular revascularisation<br/> <b>Comparison:</b> conservative therapy (i.e. supervised exercise)<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conservative therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endovascular revascularisation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.42 standard deviations lower (0.87 lower to 0.04 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>345<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance at long term in the intervention group was 0.02 standard deviations lower (0.36 lower to 0.32 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 0.05 standard deviations lower (0.38 lower to 0.29 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>345<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance at long term in the intervention group was 0.11 standard deviations higher (0.26 lower to 0.48 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>147<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.40<br/> (0.7 to 2.8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>395<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>112 per 1000<br/> (59 to 201) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (disease‐specific)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean quality of life (disease‐specific) in the intervention group was 0.18 standard deviations higher (0.04 lower to 0.41 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>301<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). Pooled standardised mean differences were interpreted using rules of thumb (&lt; 0.40 = small, 0.40 to 0.70 = moderate, &gt; 0.70 = large effect), as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).<br/> CI: confidence interval; OR: odds ratio; RCT: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Supervised exercise consisted of only supervised exercise in four studies and a combination of supervised exercise and pharmacotherapy with cilostazol in one study.<br/> <sup>2</sup> Evidence of inconsistency due to substantial heterogeneity between studies; therefore quality of the evidence downgraded one level.<br/> <sup>3</sup> The possibility of publication bias could not be ruled out, yet we did not consider it sufficient to downgrade the quality of the evidence.<br/> <sup>4</sup> In one of three studies, risk of attrition bias judged as "high"; therefore quality of the evidence downgraded one level.<br/> <sup>5</sup> Small sample size with wide confidence interval for treatment effect; therefore quality of the evidence downgraded one level. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010512-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endovascular revascularisation plus conservative therapy compared with conservative therapy alone for intermittent claudication</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Endovascular revascularisation plus conservative therapy compared with conservative therapy alone for intermittent claudication </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> intermittent claudication<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> endovascular revascularisation plus conservative therapy (supervised exercise or pharmacotherapy with cilostazol)<br/> <b>Comparison:</b> conservative therapy (supervised exercise or pharmacotherapy with cilostazol)<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conservative therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endovascular revascularisation plus conservative therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Conservative therapy consists of supervised exercise</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.26 standard deviations higher (0.13 lower to 0.64 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>432<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance at long term in the intervention group was 1.18 standard deviations higher (0.65 higher to 1.70 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 0.33 standard deviations higher (0.26 lower to 0.93 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>305<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the studies reported any quantitative data on pain‐free walking distance at long term </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.27<br/> (0.13 to 0.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>457<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>164 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/> (25 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (disease‐specific)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean quality of life (disease‐specific) in the intervention group was 0.25 standard deviations higher (0.05 lower to 0.56 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>330<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Conservative therapy consists of pharmacotherapy (cilostazol)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.38 standard deviations higher (0.08 higher to 0.68 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance at long term in the intervention group was 0.72 standard deviations higher (0.09 higher to 1.36 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only 1 small RCT included in this analysis, no meaningful grading of quality of evidence possible </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 0.63 standard deviations higher (0.33 higher to 0.94 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance at long‐term in the intervention group was 0.54 standard deviations higher (0.08 lower to 1.17 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only one small RCT included in this analysis, no meaningful grading of quality of evidence possible </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.83<br/> (0.49 to 6.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>199<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (35 to 337) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (disease‐specific)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean quality of life (disease‐specific) in the intervention group was 0.59 standard deviations higher (0.27 higher to 0.91 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). Pooled standardised mean differences were interpreted using rules of thumb (&lt; 0.40 = small, 0.40 to 0.70 = moderate, &gt; 0.70 = large effect), as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).<br/> CI: confidence interval; OR: odds ratio; RCT: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Conservative therapy consisted of supervised exercise in three studies and of pharmacotherapy with cilostazol and only advice to exercise in two studies.<br/> <sup>2</sup> The possibility of publication bias could not be ruled out, yet we did not consider it sufficient to downgrade the quality of the evidence.<br/> <sup>3</sup> Evidence of inconsistency due to substantial heterogeneity between studies; therefore quality of the evidence downgraded one level.<br/> <sup>4</sup> Small sample size with wide confidence interval for treatment effect; therefore quality of the evidence downgraded one level.<br/> <sup>5</sup> In this study risk of bias on three domains judged as "unclear"; therefore quality of the evidence downgraded one level. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010512-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010512-sec-0023"></div> <section id="CD010512-sec-0024"> <h3 class="title" id="CD010512-sec-0024">Description of the condition</h3> <p>Lower extremity peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis and is considered a major cause of morbidity in the elderly population (<a href="./references#CD010512-bbs2-0051" title="VogtMT , WolfsonSK , KullerLH . Lower extremity arterial disease and the aging process: a review. Journal of Clinical Epidemiology1992;45(5):529‐42. ">Vogt 1992</a>). Intermittent claudication, the most frequent symptomatic presentation of PAD, is defined as discomfort in the legs with exertion that resolves after a short period of rest. Intermittent claudication is highly prevalent in Western countries, affecting an estimated 4.5% of the general population aged 40 years and older (<a href="./references#CD010512-bbs2-0040" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐Society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45 Suppl S:5‐67. ">Norgren 2007</a>), and is likely to become more prevalent given the ageing population. Although individuals with claudication have a relatively benign prognosis for their affected limb, with a major amputation risk of only 1% to 3% over a five‐year period (<a href="./references#CD010512-bbs2-0040" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐Society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45 Suppl S:5‐67. ">Norgren 2007</a>), their functional performance deteriorates significantly, and this results in a sedentary lifestyle (<a href="./references#CD010512-bbs2-0044" title="SieminskiDJ , GardnerAW . The relationship between free‐living daily physical activity and the severity of peripheral arterial occlusive disease. Vascular Medicine1997;2(4):286‐91. ">Sieminski 1997</a>), along with severely limited quality of life (QoL) (<a href="./references#CD010512-bbs2-0036" title="KhairaHS , HangerR , ShearmanCP . Quality of life in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;11(1):65‐9. ">Khaira 1996</a>; <a href="./references#CD010512-bbs2-0047" title="SpronkS , WhiteJV , BoschJL , HuninkMG . Impact of claudication and its treatment on quality of life. Seminars in Vascular Surgery2007;20(1):3‐9. ">Spronk 2007</a>). Additionally, claudication is associated with significantly increased risk of all‐cause and cardiovascular mortality independent of other atherosclerotic risk factors (<a href="./references#CD010512-bbs2-0032" title="GolombBA , DangTT , CriquiMH . Peripheral arterial disease: morbidity and mortality implications. Circulation2006;114(7):688‐99. ">Golomb 2006</a>; <a href="./references#CD010512-bbs2-0045" title="SmithGD , ShipleyMJ , RoseG . Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation1990;82(6):1925‐31. ">Smith 1990</a>). </p> </section> <section id="CD010512-sec-0025"> <h3 class="title" id="CD010512-sec-0025">Description of the intervention</h3> <p>Treatment of intermittent claudication consists of multiple components that focus on preventing future cardiovascular events and related mortality, as well as on ameliorating claudication symptoms. Pharmacotherapy and exercise therapy are established as effective first‐line conservative treatment options, improving walking distance and QoL in patients with claudication (<a href="./references#CD010512-bbs2-0029" title="FakhryF , van deLuijtgaardenKM , BaxL , denHoedPT , HuninkMG , RouwetEV , et al. Supervised walking therapy in patients with intermittent claudication. Journal of Vascular Surgery2012;56(4):1132‐42. ">Fakhry 2012</a>; <a href="./references#CD010512-bbs2-0034" title="HiattWR . Medical treatment of peripheral arterial disease and claudication. New England Journal of Medicine2001;344(21):1608‐21. ">Hiatt 2001</a>; <a href="./references#CD010512-bbs2-0052" title="WatsonL , EllisB , LengGC . Exercise for intermittent claudication. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD000990.pub2] ">Watson 2008</a>). However, in clinical practice, endovascular revascularisation is considered an attractive first‐line alternative owing to its immediate effect and relatively low complication rates. Although both exercise therapy and endovascular revascularisation are effective in improving symptoms, it should be noted that neither therapy completely removes the disability in most patients (<a href="./references#CD010512-bbs2-0046" title="SobieszczykPS , BeckmanJA . Intervention or exercise? The answer is yes!. Journal of the American College of Cardiology2015; Vol. 65, issue 10:1010‐2. [PUBMED: 25766948] ">Sobieszczyk 2015</a>). In 1964 Dotter and Judkins first performed and reported on endovascular revascularisation of the lower extremities (<a href="./references#CD010512-bbs2-0028" title="DotterCT , JudkinsMP . Transluminal treatment of arteriosclerotic obstruction: description of a new technic and a preliminary report of its application. Circulation1964;30(5):654‐70. ">Dotter 1964</a>). Since that time, important technological developments including the introduction of balloon angioplasty and drug‐eluting balloons and stents has advanced endovascular revascularisation as a safe and durable treatment option for management of symptomatic PAD. Endovascular revascularisation is performed with the patient under local anaesthesia, and access to the stenosed or occluded peripheral artery is usually gained via the common femoral artery. Subsequently, an angioplasty procedure that involves (balloon) dilatation of a stenosed peripheral artery or recanalisation of an occluded peripheral artery is performed. This is followed by stent placement if suboptimal results are achieved with angioplasty only (<a href="./references#CD010512-bbs2-0050" title="TetterooE , van derGraafY , BoschJL , vanEngelenAD , HuninkMG , EikelboomBC , et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac‐artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet1998;351(9110):1153‐9. ">Tetteroo 1998</a>). After a successful endovascular revascularisation procedure, patients are usually ambulatory on the same day and are able to resume all normal activities within a few days. Furthermore, <a href="./references#CD010512-bbs2-0049" title="StewartKJ , HiattWR , RegensteinerJG , HirschAT . Exercise training for claudication. New England Journal of Medicine2002;347(24):1941‐51. ">Stewart 2002</a> reported procedure‐related morbidity and mortality lower than 0.5%, and <a href="./references#CD010512-bbs2-0038" title="MatsiPJ , ManninenHI . Complications of lower‐limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovascular and Interventional Radiology1998;21(5):361‐6. ">Matsi 1998</a> described haematoma at the puncture site and embolisation as the most common procedure‐related complications. </p> </section> <section id="CD010512-sec-0026"> <h3 class="title" id="CD010512-sec-0026">How the intervention might work</h3> <p>After successful revascularisation, whereby the obstruction or occlusion in the peripheral artery is resolved and improved blood flow is restored, arterial perfusion in the lower extremity improves significantly. This is confirmed by significant improvement in the ankle brachial index (ABI) immediately after the procedure. Randomised controlled trials (RCTs) have demonstrated the effectiveness of endovascular revascularisation in improving functional performance (i.e. walking distance and ABI) and QoL in individuals with intermittent claudication (<a href="./references#CD010512-bbs2-0027" title="BoschJL , van derGraafY , HuninkMG . Health‐related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation1999;99(24):3155‐60. ">Bosch 1999</a>; <a href="./references#CD010512-bbs2-0039" title="MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. ">Mazari 2012</a>; <a href="./references#CD010512-bbs2-0048" title="SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. ">Spronk 2009a</a>). </p> </section> <section id="CD010512-sec-0027"> <h3 class="title" id="CD010512-sec-0027">Why it is important to do this review</h3> <p>Intermittent claudication is a serious lifestyle‐limiting symptom of PAD that has a large impact on patients' functional performance and QoL. Conservative treatment strategies, including pharmacotherapy and supervised exercise therapy, are recommended as first‐line therapy for claudication (<a href="./references#CD010512-bbs2-0040" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐Society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45 Suppl S:5‐67. ">Norgren 2007</a>; <a href="./references#CD010512-bbs2-0042" title="RookeTW , HirschAT , MisraS , SidawyAN , BeckmanJA , FindeissLK , et al. 2011 ACCF/AHA focused update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology2011;58(19):2020‐45. ">Rooke 2011</a>). Yet their value in clinical practice remains uncertain, as medical drugs for claudication (e.g. cilostazol, pentoxifylline, naftidrofuryl) have limited effects (<a href="./references#CD010512-bbs2-0026" title="BergerJS , HiattWR . Medical therapy in peripheral artery disease. Circulation2012;126(4):491‐500. ">Berger 2012</a>), and supervised exercise programmes are under‐utilised in clinical practice owing to limited access (<a href="./references#CD010512-bbs2-0037" title="MakrisGC , LattimerCR , LavidaA , GeroulakosG . Availability of supervised exercise programs and the role of structured home‐based exercise in peripheral arterial disease. European Journal of Vascular and Endovascular Surgery2012;44(6):569‐75. ">Makris 2012</a>), reimbursement issues, and poor patient compliance (<a href="./references#CD010512-bbs2-0029" title="FakhryF , van deLuijtgaardenKM , BaxL , denHoedPT , HuninkMG , RouwetEV , et al. Supervised walking therapy in patients with intermittent claudication. Journal of Vascular Surgery2012;56(4):1132‐42. ">Fakhry 2012</a>). Consequently, researchers are noting an enormous increase in the use of endovascular revascularisation as first‐line therapy for claudication (<a href="./references#CD010512-bbs2-0023" title="AndersonPL , GelijnsA , MoskowitzA , AronsR , GuptaL , WeinbergA , et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980‐2000. Journal of Vascular Surgery2004;39(6):1200‐8. ">Anderson 2004</a>; <a href="./references#CD010512-bbs2-0025" title="BeckmanJA . Peripheral endovascular revascularization: some proof in the pudding?. Circulation2007;115(5):550‐2. ">Beckman 2007</a>). Nonetheless, the (long‐term) effectiveness of endovascular revascularisation as first‐line therapy for intermittent claudication remains debatable. The only Cochrane review on this topic, which included two studies with a total of 98 participants comparing angioplasty versus non‐surgical therapy, concluded that limited data suggest short‐term benefit in favour of angioplasty (<a href="./references#CD010512-bbs2-0030" title="FowkesFG , GillespieIN . Angioplasty (versus non‐surgical management) for intermittent claudication. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000017] ">Fowkes 2000</a>). Since the last update of this review, new randomised trials assessing the efficacy of endovascular revascularisation compared with conservative treatment have published their findings. Furthermore, new clinical studies have investigated the combination of exercise therapy and endovascular revascularisation, which takes advantage of immediate short‐term effects of revascularisation and long‐term benefits of exercise therapy (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0039" title="MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. ">Mazari 2012</a>). However, clinical studies rarely have sufficient power to detect intervention effectiveness in terms of clinical outcomes such as functional performance, QoL, or cardiovascular events. Therefore, a Cochrane review identifying these studies systematically, evaluating their results independently, and updating results when new studies are published is important for reducing uncertainty about the (added) value of endovascular revascularisation in the management of patients with intermittent claudication. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010512-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010512-sec-0028"></div> <p>The main objective of this systematic review is to summarise the (added) effects of endovascular revascularisation on functional performance and QoL in the management of intermittent claudication. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010512-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010512-sec-0029"></div> <section id="CD010512-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010512-sec-0031"> <h4 class="title">Types of studies</h4> <p>We systematically searched for and included only RCTs with parallel‐group design comparing outcomes of endovascular revascularisation (with and without conservative therapy) versus no specific therapy or versus conservative therapy (i.e. supervised exercise or pharmacotherapy) in patients with intermittent claudication. </p> <p>We included only studies comparing endovascular revascularisation (± conservative therapy) versus conservative therapies or no specific therapy for intermittent claudication. We excluded studies providing any kind of surgical revascularisation in the comparison group. We also excluded studies comparing different types of endovascular revascularisation procedures (e.g. angioplasty vs angioplasty plus stenting).    </p> </section> <section id="CD010512-sec-0032"> <h4 class="title">Types of participants</h4> <p>Patients with stable intermittent claudication, according to Rutherford category 1 to 3 or Fontaine stage II (<a href="./references#CD010512-bbs2-0040" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐Society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45 Suppl S:5‐67. ">Norgren 2007</a>), who are eligible for both endovascular revascularisation and conservative management. </p> </section> <section id="CD010512-sec-0033"> <h4 class="title">Types of interventions</h4> <p>In the intervention group, participants underwent endovascular revascularisation (± conservative therapy). We considered all percutaneous endovascular revascularisation procedures including angioplasty (any type, e.g. balloon, laser) or angioplasty plus (selective) stent placement (any type of stent including drug‐eluting) for atherosclerotic lesion(s) in arteries of the lower extremity. In the comparison group, participants received only conservative therapy or no specific therapy for intermittent claudication. Conservative therapy included specific pharmacotherapy for intermittent claudication (e.g. cilostazol, pentoxifylline, naftidrofuryl) or supervised exercise therapy. </p> <p>We considered the following comparisons.</p> <p> <ul id="CD010512-list-0001"> <li> <p>Endovascular revascularisation versus no specific therapy for intermittent claudication except verbal advice to exercise. </p> </li> <li> <p>Endovascular revascularisation versus conservative therapy (pharmacotherapy or supervised exercise). </p> </li> <li> <p>Endovascular revascularisation plus conservative therapy versus conservative therapy.</p> </li> </ul> </p> <p>When investigators provided cardiovascular risk factor modification (e.g. lipid control, hypertension control, anti‐smoking advice) in the intervention group, it was also provided equally in the comparison group.      </p> </section> <section id="CD010512-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD010512-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010512-list-0002"> <li> <p>Functional performance outcomes</p> <ul id="CD010512-list-0003"> <li> <p>Maximum walking distance (MWD), as assessed on a treadmill</p> </li> <li> <p>Pain‐free walking distance (PFWD), as assessed on a treadmill</p> </li> </ul> </li> <li> <p>Secondary invasive interventions during follow‐up</p> <ul id="CD010512-list-0004"> <li> <p>Endovascular or surgical revascularisation</p> </li> <li> <p>Amputation</p> </li> </ul> </li> </ul> </p> </section> <section id="CD010512-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010512-list-0005"> <li> <p>Quality of life, including health‐related (general and disease‐specific) QoL measures</p> </li> <li> <p>Procedure‐related complications (e.g. local haematoma, artery dissection, embolisation)</p> </li> <li> <p>Cardiovascular events (e.g. myocardial infarction, stroke)</p> </li> <li> <p>Functional performance measures not assessed on a treadmill (e.g. six‐minute walk test, self‐reported walking distance) </p> </li> <li> <p>Mortality</p> </li> </ul> </p> </section> </section> </section> <section id="CD010512-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <p>We applied no language restrictions.</p> <section id="CD010512-sec-0038"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist (CIS) searched the following databases for relevant trials. </p> <p> <ul id="CD010512-list-0006"> <li> <p>Cochrane Vascular Specialised Register (21 February 2017).</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1) via the Cochrane Register of Studies Online. </p> </li> </ul> </p> <p>See <a href="./appendices#CD010512-sec-0111">Appendix 1</a> for details of the search strategy used to search CENTRAL. </p> <p>The Cochrane Vascular Specialised Register is maintained by the CIS and is constructed from weekly electronic searches of MEDLINE Ovid, Embase Ovid, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and the Allied and Complementary Medicine Database (AMED), and through handsearching of relevant journals. We have provided the full list of databases, journals, and conference proceedings searched, as well as the search strategies used, in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Vascular Module in the Cochrane Library (<a href="http://www.cochranelibrary.com/" target="_blank">www.cochranelibrary.com</a>). </p> <p>The CIS also searched the following trials registries for details of ongoing and unpublished studies (21 February 2017). </p> <p> <ul id="CD010512-list-0007"> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp/search/en/" target="_blank">www.who.int/trialsearch</a>). </p> </li> <li> <p>International Standard Randomised Controlled Trial Number (ISRCTN) Register (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a>). </p> </li> </ul> </p> <p>See <a href="./appendices#CD010512-sec-0112">Appendix 2</a>. </p> </section> <section id="CD010512-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of all eligible studies for additional relevant studies. </p> </section> </section> <section id="CD010512-sec-0040"> <h3 class="title" id="CD010512-sec-0040">Data collection and analysis</h3> <section id="CD010512-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (FF and HF) initially selected identified studies independently upon reviewing titles and abstracts. Final selection was based on full‐text evaluation of selected studies by the two review authors (FF and HF) working independently. Review authors discussed and resolved disagreements by consensus. If no consensus was reached, a third review author (MH) acted as arbiter. </p> </section> <section id="CD010512-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (FF and HF) extracted all required data from each included study using a standardised form, which consisted of (1) study characteristics including study design, year of publication, study location, source of funding, sample size estimation, follow‐up, and applied inclusion and exclusion criteria; (2) participant baseline characteristics including number of participants in each group, mean age, and gender distribution; (3) intervention characteristics, compliance, and losses to follow‐up; and (4) primary and secondary outcomes, as specified under <a href="#CD010512-sec-0034">Types of outcome measures</a>. </p> </section> <section id="CD010512-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (FF and HF) independently assessed the methodological quality of included studies, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), for the following domains. </p> <p> <ul id="CD010512-list-0008"> <li> <p>Randomisation and sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding (of participants, personnel, and outcome assessors).</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Publication and other sources of bias.</p> </li> </ul> </p> <p>For each of the six domains, we assessed risk of bias as 'low' or 'high', or as 'unclear' when available information was insufficient to permit judgement on risk of bias. </p> </section> <section id="CD010512-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>To analyse the treatment effect of endovascular revascularisation in each study for continuous outcome measures, including the primary outcomes MWD and PFWD and the secondary outcome QoL, we extracted the value of each outcome measure at different time points (6 to 12 months and over the long term) for both intervention and comparison groups. For studies reporting treadmill walking time instead of treadmill walking distance, we calculated MWD and PFWD by converting walking time to distance using the reported treadmill speed. </p> <p>Given large variation in the intensity of treadmill protocols to assess MWD and PFWD and use of different instruments to assess QoL in each study, we used standardised mean differences (SMDs) and 95% confidence intervals (CIs) as treatment effects for these outcome measures to allow standardisation of results to a uniform scale. We calculated the pooled SMD, which is the pooled treatment difference between groups normalised to the pooled standard deviation of the difference, as treatment effect size in meta‐analysis. We interpreted pooled SMDs using rules of thumb (&lt; 0 .40 = small effect, 0.40 to 0.70 = moderate effect, &gt; 0.70 = large effect), as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>For dichotomous outcome measures, including secondary invasive intervention, procedure‐related complications, cardiovascular events, or death during follow‐up in each treatment group, we calculated odds ratios (ORs) and corresponding 95% CIs as measures of treatment effect, if appropriate. </p> </section> <section id="CD010512-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>In this systematic review, we included only RCTs with parallel‐group design. The unit of randomisation was the individual participant.   </p> </section> <section id="CD010512-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>In the case of missing data on dropouts, withdrawals, and outcome measures, we contacted the original investigators and requested data when appropriate. If studies reported medians and interquartile ranges (IQRs) as measures of variance for walking distance, we converted these values to means and standard deviations (SDs), assuming a normal distribution for walking distance so we could include these studies in the meta‐analysis. We tested this assumption by performing sensitivity analysis. Missing data indicating the variance of outcome measures (e.g. SD, CI) were to be expected, in which case we used the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) to calculate or impute these data.   </p> </section> <section id="CD010512-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the statistical heterogeneity of outcome measures by calculating the Q statistics and the I² statistic, as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010512-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>We created a funnel plot providing enough studies were included for each outcome measure, with effect size on the x‐axis and precision on the y‐axis to investigate possible publication bias. </p> </section> <section id="CD010512-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We calculated treatment effects using corresponding 95% CIs for both continuous and dichotomous outcome measures by applying random‐effects models. Subsequently, when appropriate, we calculated the pooled treatment effect size from the random‐effects model meta‐analysis and presented this as a forest plot for each outcome measure separately. We considered two‐sided P ≤ 0.05 as statistically significant and performed all data analyses using RevMan 5.3 (<a href="./references#CD010512-bbs2-0041" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), when appropriate.   </p> </section> <section id="CD010512-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We considered the following subgroup analyses for primary outcomes, provided we identified enough studies for each subgroup. </p> <p> <ul id="CD010512-list-0009"> <li> <p>Types of endovascular revascularisation procedures (e.g. angioplasty, angioplasty plus stenting). </p> </li> <li> <p>Types of pharmacotherapy (e.g. cilostazol, pentoxifylline, naftidrofuryl).</p> </li> <li> <p>Types of exercise therapy (i.e. supervised or non‐supervised programme).</p> </li> <li> <p>Separate segments (i.e. aortoiliac, femoropopliteal, or combined).</p> </li> </ul> </p> </section> <section id="CD010512-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform several sensitivity analyses provided we could include enough studies in the meta‐analysis. We assessed individual study effects by excluding each study separately from the analysis to examine whether exclusion of an individual study would significantly change the results. Likewise we planned to perform sensitivity analysis on the methodological quality of studies by removing studies with high risk of (methodological) bias to observe whether excluding these studies would significantly change the results. In addition, in performing sensitivity analyses, we removed from meta‐analysis studies reporting only median and IQR walking distances, to observe whether excluding these studies would significantly change the results. </p> <section id="CD010512-sec-0052"> <h5 class="title">'Summary of findings'</h5> <p>We presented in 'Summary of findings' tables the main findings of this review concerning quality of evidence, magnitude of effect of interventions examined, and sum of available data for the outcomes MWD, PFWD, secondary invasive interventions, and disease‐specific QoL, according to GRADE methods as described by <a href="./references#CD010512-bbs2-0043" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a> and <a href="./references#CD010512-bbs2-0024" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐4. ">Atkins 2004</a>. We used GRADEprofiler (GRADEpro) software to assist in preparation of a 'Summary of findings' table for each comparison assessed in this review (<a href="./references#CD010512-bbs2-0033" title="Version accessed February 2017. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc), 2015. GRADEpro Guideline Development Tool. Version accessed February 2017. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc), 2015, Available from gradepro.org. ">GRADEPro 2015</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010512-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010512-sec-0053"></div> <section id="CD010512-sec-0054"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD010512-sec-0120" title="">Characteristics of included studies</a>, <a href="./references#CD010512-sec-0121" title="">Characteristics of excluded studies</a>, and <a href="./references#CD010512-sec-0122" title="">Characteristics of ongoing studies</a>. </p> <section id="CD010512-sec-0055"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD010512-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010512-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010512-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010512-sec-0056"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD010512-sec-0120" title="">Characteristics of included studies</a>. </p> <p>After full‐text assessment, we included in this systematic review ten studies described in 25 publications assessing the value of endovascular revascularisation in the management of patients with intermittent claudication (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). Results from all included studies had been published in peer‐reviewed journals. <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a> reported two separate trials that included participants in one of the two trials on the basis of lesion site (femoropopliteal or aortoiliac) and consequently randomised them to one of two treatment arms. <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> randomised participants to a non‐invasive treatment group or an invasive treatment group that included both open surgical or endovascular revascularisation procedures at baseline. To include this study in this systematic review, we sought and received from study authors outcome data from the subgroup of participants undergoing endovascular revascularisation. </p> <p>All included studies used a parallel‐group design, with seven studies randomising between two arms comparing endovascular revascularisation versus cardiovascular risk factor management alone (i.e. no specific therapy for intermittent claudication except verbal advice to exercise) (<a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>), endovascular revascularisation versus supervised exercise (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>), endovascular revascularisation plus supervised exercise versus supervised exercise alone (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>), or endovascular revascularisation plus cilostazol 100 mg twice daily versus cilostazol 100 mg twice daily (<a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>). Three studies had three arms comparing endovascular revascularisation versus cardiovascular risk factor management alone (i.e. no specific therapy for claudication) versus supervised exercise (<a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>), endovascular revascularisation versus supervised exercise versus endovascular revascularisation plus supervised exercise (<a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>), or endovascular revascularisation plus cilostazol 100 mg twice daily versus cilostazol 100 mg twice daily alone versus supervised exercise plus cilostazol 100 mg twice daily (<a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>). </p> <p>All studies were conducted in Europe (n = 9) and North America (n = 1) and recruited a total number of 1087 participants, ranging from 23 to 212 participants in each individual study. All participants had stable intermittent claudication, and most were recruited from outpatient clinics in university and non‐university hospitals. Seven out of ten studies included participants with claudication due to both aortoiliac and femoropopliteal disease (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>), two studies included only participants with femoropopliteal disease (<a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>), and one study included only participants with aortoiliac disease (<a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>). Most included participants were male (61%) with an average age ranging from 61 to 70 years. </p> <p>All studies except <a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a> reported to a greater or lesser extent some sort of cardiovascular risk factor management (e.g. providing smoking cessation advice, promoting physical activity, providing dietary advice or medical therapy for cardiovascular risk factors) offered to participants in each treatment arm at the start of the study, in addition to their specific treatment for intermittent claudication, if applicable. In all studies, endovascular revascularisation consisted of balloon angioplasty; in four studies, investigators placed a stent if initial balloon angioplasty results were unsatisfactory (selective stenting) (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>); <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> always placed a stent after initial balloon angioplasty (primary stenting); <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> always placed a stent in the aortoiliac segment (primary stenting) but placed a stent in the femoropopliteal segment only if angioplasty results were unsatisfactory (selective stenting); and four studies placed no stent and performed only balloon angioplasty (no stenting) (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). In studies comparing endovascular revascularisation (± conservative therapy) versus conservative therapy for intermittent claudication, conservative treatment consisted of pharmacotherapy with cilostazol 100 mg twice daily in <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> and <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>, comprised a supervised exercise programme in six studies (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>), and included a combination of cilostazol 100 mg twice daily and supervised exercise in <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>. The duration of supervised exercise programmes varied between studies, with most studies offering a programme of 12 weeks with a frequency of two to three sessions per week. <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> and <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a> continued the supervised exercise programme until six months, and <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a> continued the programme up to 12 months, with a declining number of sessions per week after the initial three months of training depending on participants' progress. </p> <p>Duration of follow‐up was homogeneous between studies, with all studies reporting a follow‐up duration of at least six months. Eight out of ten studies recorded outcome measures at 12 months' follow‐up (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>); six studies reported long‐term follow‐up (longer than 12 months), with follow‐up duration of 18 months in one study (<a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>), two years in three studies (<a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>), six years in one study (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>), and seven years in another study (<a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). </p> <p>In assessing functional performance measures (i.e. MWD and PFWD), studies used different treadmill protocols with varying treadmill speed and incline and total duration of assessment. Six studies used a 10% incline with treadmill speed between 2.5 km/h and 4 km/h and duration from 5 to 20 minutes (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). Two studies used a treadmill protocol with constant speed of 3.2 km/h and graded incline starting at 0%, increasing each two minutes up to a maximum of 10% (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>). <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a> recorded walking distances up to 30 minutes walking on the treadmill, and <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> limited this time to 12 minutes. <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> used a treadmill protocol with progressively increasing incline (0 to 12%) and speed (1.5 to 4.5 km/h). In the final study (<a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>), the treadmill protocol allowed no graded incline and used a constant speed of 3.5 km/h, permitting participants to walk up to 30 minutes on the treadmill. </p> <p>Nine out of ten studies reported secondary invasive (endovascular or surgical) interventions during follow‐up (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>), but only four studies explicitly reported data on numbers of amputations (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). Seven studies reported data on general QoL (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>), and six studies presented data on disease‐specific QoL (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>), yet the validated questionnaires used to assess QoL were quite heterogeneous between studies (see <a href="./references#CD010512-sec-0120" title="">Characteristics of included studies</a> for details). </p> </section> <section id="CD010512-sec-0057"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD010512-sec-0121" title="">Characteristics of excluded studies</a>. </p> <p>After full‐text assessment, we excluded nine studies (<a href="./references#CD010512-bbs2-0011" title="BoE , HisdalJ , CvancarovaM , StrandenE , JorgensenJJ , SandbaekG , et al. Twelve‐months follow‐up of supervised exercise after percutaneous transluminal angioplasty for intermittent claudication: a randomised clinical trial. International Journal of Environmental Research and Public Health2013;10(11):5998‐6014. ">Bo 2013</a>; <a href="./references#CD010512-bbs2-0012" title="BrodmannM , RiefP , FroehlichH , DorrA , GaryT , EllerP , et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovascular and Interventional Radiology2013;36(1):69‐74. ">Brodmann 2013</a>; <a href="./references#CD010512-bbs2-0013" title="GabrielliR , RosatiMS , VitaleS , BaciarelloG , SianiA , ChiappaR , et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter‐Society Consensus II D femoropopliteal lesions. Journal of Vascular Surgery2012;56(6):1598‐605. ">Gabrielli 2012</a>; <a href="./references#CD010512-bbs2-0014" title="GelinJ , JivegardL , TaftC , KarlssonJ , SullivanM , DahllofAG , et al. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements. European Journal of Vascular and Endovascular Surgery2001;22(2):107‐13. [PUBMED: 11472042] ">Gelin 2001</a>; <a href="./references#CD010512-bbs2-0015" title="GiuglianoG , DiSerafinoL , PerrinoC , SchianoV , LaurenzanoE , CasseseS , et al. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. International Journal of Cardiology2013;167(6):2566‐71. ">Giugliano 2013</a>; <a href="./references#CD010512-bbs2-0016" title="HeiderP , WildgruberM , WolfO , SchusterT , LutzenbergerW , BergerH , et al. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1. Prostaglandins &amp; Other Lipid Mediators2009;88(1‐2):23‐30. [PUBMED: 18832042] ">Heider 2009</a>; <a href="./references#CD010512-bbs2-0017" title="HusmannM , Dorffler‐MellyJ , KalkaC , DiehmN , BaumgartnerI , SilvestroA . Successful lower extremity angioplasty improves brachial artery flow‐mediated dilation in patients with peripheral arterial disease. Journal of Vascular Surgery2008;48(5):1211‐6. ">Husmann 2008</a>; <a href="./references#CD010512-bbs2-0018" title="KruidenierLM , NicolaïSP , RouwetEV , PetersRJ , PrinsMH , TeijinkJAW . Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial. Journal of Vascular and Interventional Radiology2011;22(7):961‐8. ">Kruidenier 2011</a>; <a href="./references#CD010512-bbs2-0019" title="ThomsonIA , vanRijAM , MorrisonND , PackerSGK , ChristieR . A ten year randomised controlled trial of percutaneous femoropopliteal angioplasty for claudication. Australia and New Zealand Journal of Surgery1999; Vol. 69, issue Suppl:98. ">Thomson 1999</a>). <a href="./references#CD010512-bbs2-0014" title="GelinJ , JivegardL , TaftC , KarlssonJ , SullivanM , DahllofAG , et al. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements. European Journal of Vascular and Endovascular Surgery2001;22(2):107‐13. [PUBMED: 11472042] ">Gelin 2001</a> reported outcome measures for participants randomised to open or endovascular revascularisation as one invasive treatment group, and corresponding authors could provide no data for the subgroup of participants receiving endovascular revascularisation. For this reason, we decided to exclude this study from further evaluation. We excluded another eight studies for not including a non‐interventional control group (<a href="./references#CD010512-bbs2-0011" title="BoE , HisdalJ , CvancarovaM , StrandenE , JorgensenJJ , SandbaekG , et al. Twelve‐months follow‐up of supervised exercise after percutaneous transluminal angioplasty for intermittent claudication: a randomised clinical trial. International Journal of Environmental Research and Public Health2013;10(11):5998‐6014. ">Bo 2013</a>; <a href="./references#CD010512-bbs2-0012" title="BrodmannM , RiefP , FroehlichH , DorrA , GaryT , EllerP , et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovascular and Interventional Radiology2013;36(1):69‐74. ">Brodmann 2013</a>; <a href="./references#CD010512-bbs2-0013" title="GabrielliR , RosatiMS , VitaleS , BaciarelloG , SianiA , ChiappaR , et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter‐Society Consensus II D femoropopliteal lesions. Journal of Vascular Surgery2012;56(6):1598‐605. ">Gabrielli 2012</a>; <a href="./references#CD010512-bbs2-0018" title="KruidenierLM , NicolaïSP , RouwetEV , PetersRJ , PrinsMH , TeijinkJAW . Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial. Journal of Vascular and Interventional Radiology2011;22(7):961‐8. ">Kruidenier 2011</a>), not providing relevant outcome measures for this systematic review (<a href="./references#CD010512-bbs2-0016" title="HeiderP , WildgruberM , WolfO , SchusterT , LutzenbergerW , BergerH , et al. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1. Prostaglandins &amp; Other Lipid Mediators2009;88(1‐2):23‐30. [PUBMED: 18832042] ">Heider 2009</a>; <a href="./references#CD010512-bbs2-0017" title="HusmannM , Dorffler‐MellyJ , KalkaC , DiehmN , BaumgartnerI , SilvestroA . Successful lower extremity angioplasty improves brachial artery flow‐mediated dilation in patients with peripheral arterial disease. Journal of Vascular Surgery2008;48(5):1211‐6. ">Husmann 2008</a>), not using a formal randomisation process (<a href="./references#CD010512-bbs2-0015" title="GiuglianoG , DiSerafinoL , PerrinoC , SchianoV , LaurenzanoE , CasseseS , et al. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. International Journal of Cardiology2013;167(6):2566‐71. ">Giugliano 2013</a>), or publishing only abstract data, with study authors not able to provide additional data (<a href="./references#CD010512-bbs2-0019" title="ThomsonIA , vanRijAM , MorrisonND , PackerSGK , ChristieR . A ten year randomised controlled trial of percutaneous femoropopliteal angioplasty for claudication. Australia and New Zealand Journal of Surgery1999; Vol. 69, issue Suppl:98. ">Thomson 1999</a>). </p> <section id="CD010512-sec-0058"> <h5 class="title">Ongoing studies</h5> <p>We classified two studies as ongoing studies (<a href="./references#CD010512-bbs2-0020" title="FransFA , BipatS , ReekersJA , LegemateDA , KoelemayMJW . SUPERvised exercise therapy or immediate PTA for intermittent claudication in patients with an iliac artery obstruction ‐ a multicentre randomised controlled trial; SUPER study design and rationale. European Journal of Vascular and Endovascular Surgery2012;43(4):466‐71. ">Frans 2012a</a>; <a href="./references#CD010512-bbs2-0021" title="NCT01230229 . Primary stenting vs conservative treatment in claudicants ‐ a study on quality of life. www.clinicaltrials.gov/ct2/show/NCT01230229 (date first received 28 October 2010). ">NCT01230229</a>) (see <a href="./references#CD010512-sec-0122" title="">Characteristics of ongoing studies</a>). </p> </section> </section> </section> <section id="CD010512-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD010512-fig-0002">Figure 2</a> and <a href="#CD010512-fig-0003">Figure 3</a> for a graphical summary of risk of bias for the ten included studies. </p> <div class="figure" id="CD010512-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010512-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010512-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010512-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010512-sec-0060"> <h4 class="title">Allocation</h4> <p>Although all ten included studies were RCTs, seven studies described an adequate sequence generation method performed by means of computerised randomisation (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). In the remaining three studies, researchers randomised participants to one of the treatment arms, yet did not report the exact sequence generation methods used, making adequate judgement of risk of bias impossible (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>). Similarly, most studies reported an adequate allocation concealment method (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). Two studies provided insufficient information to allow a definitive judgement on concealment (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>). </p> </section> <section id="CD010512-sec-0061"> <h4 class="title">Blinding</h4> <p>None of the included studies performed blinding of participants and personnel to the allocated treatment, given the nature of endovascular revascularisation as the intervention in each study. This might have introduced performance bias. Detection bias could be avoided by blinding outcome assessors, which three studies adequately performed and described (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). The remaining seven studies provided no information on assessor blinding; thus we determined risk of detection bias to be unclear in these studies. </p> </section> <section id="CD010512-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>We determined risk of attrition bias to be low in eight studies, as censoring at 6 to 18 months' follow‐up (if applicable) was minimal to moderate, and numbers and reasons for censoring across allocated groups were well balanced (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). For one study, we assessed risk of attrition bias to be high, as at 12 months' follow‐up, a significant number of participants were not available for primary outcome assessment and information provided on distribution and reasons for dropouts was insufficient (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>). <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a> excluded from analysis participants in the control group who underwent endovascular or open revascularisation, which might have introduced attrition bias, yet information on characteristics of these participants was insufficient to allow judgement for risk of bias. </p> </section> <section id="CD010512-sec-0063"> <h4 class="title">Selective reporting</h4> <p>In nine studies (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>), investigators reported all relevant and expected outcome measures in the results section. In contrast to maximum walking distance, <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a> reported no absolute values for pain‐free walking distance but rather percentage of participants attaining 200 metres without claudication pain; this was not prespecified in the methods section of this study. </p> </section> <section id="CD010512-sec-0064"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a> received unrestricted grants from the industry, and <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> and <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a> received partial support from the industry. Owing to slow recruitment in five studies (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>), investigators were unable to include their prespecified intended sample size based on power calculations for the primary outcome measure of walking distance, and this may have biased results. </p> </section> </section> <section id="CD010512-sec-0065"> <h3 class="title" id="CD010512-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD010512-tbl-0001"><b>Summary of findings for the main comparison</b> Endovascular revascularisation compared with no specific therapy for intermittent claudication except verbal advice to exercise</a>; <a href="./full#CD010512-tbl-0002"><b>Summary of findings 2</b> Endovascular revascularisation compared with conservative therapy for intermittent claudication</a>; <a href="./full#CD010512-tbl-0003"><b>Summary of findings 3</b> Endovascular revascularisation plus conservative therapy compared with conservative therapy alone for intermittent claudication</a> </p> <section id="CD010512-sec-0066"> <h4 class="title">Comparison 1. Endovascular revascularisation versus no specific therapy for intermittent claudication except verbal advice to exercise </h4> <p>Data from three studies comparing endovascular revascularisation versus no specific therapy for intermittent claudication (i.e. only cardiovascular risk factor management and verbal advice on exercise) were eligible for inclusion with a total sample size of 134 participants (<a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). </p> <section id="CD010512-sec-0067"> <h5 class="title">Maximum walking distance</h5> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from three studies (n = 125) showed that participants had higher MWD following endovascular revascularisation than after no specific therapy (<a href="./references#CD010512-fig-0006" title="">Analysis 1.1</a>), with a pooled SMD of 0.70 (95% CI 0.31 to 1.08; P = 0.0004), which is equivalent to a moderate effect in favour of endovascular revascularisation. There was little heterogeneity (I² = 8%). </p> <p>After long‐term follow‐up, use of a random‐effects model and pooled data from two studies (n = 103) showed no clear differences in MWD between participants following endovascular revascularisation compared with those given no specific therapy (pooled SMD 0.67, 95% CI ‐0.30 to 1.63; P = 0.18) (<a href="./references#CD010512-fig-0007" title="">Analysis 1.2</a>). Heterogeneity was substantial (I² = 83%). </p> </section> <section id="CD010512-sec-0068"> <h5 class="title">Pain‐free walking distance</h5> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from three studies (n = 125) showed that participants following endovascular revascularisation had higher PFWD compared with those given no specific therapy (<a href="./references#CD010512-fig-0008" title="">Analysis 1.3</a>), with a pooled SMD of 1.29 (95% CI 0.90 to 1.68; P &lt; 0.00001); this is equivalent to a large effect in favour of endovascular revascularisation. There was little heterogeneity (I² = 0%). </p> <p>After long‐term follow‐up, use of a random‐effects model and pooled data from two studies (n = 103) showed no clear differences in PFWD between participants following endovascular revascularisation and those given no specific therapy (pooled SMD 0.69, 95% CI ‐0.45 to 1.82; P = 0.24) (<a href="./references#CD010512-fig-0009" title="">Analysis 1.4</a>). Heterogeneity was considerable (I² = 87%). </p> </section> <section id="CD010512-sec-0069"> <h5 class="title">Secondary invasive interventions</h5> <p>Two studies reported data on the number of secondary invasive interventions during follow‐up (<a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). During two‐year follow‐up, investigators performed a secondary invasive intervention in 4 of 58 participants in the endovascular revascularisation group and in 5 of 60 participants in the no specific therapy group (OR 0.8, 95% CI 0.12 to 5.28; P = 0.82). There was little heterogeneity (I² = 29%) (<a href="./references#CD010512-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD010512-sec-0070"> <h5 class="title">Quality of life</h5> <p><a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a> assessed disease‐specific QoL using Claudication Scale (CLAU‐S) forms and reported no significant differences in all seven domains of the questionnaire between the two study groups after two years of follow‐up. </p> <p>Two studies assessed and reported on general health‐related QoL (<a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a> used Nottingham Health Profile scores (six domains) to show no significant differences between groups in any domains during follow‐up (P &gt; 0.05). <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a> used the Short Form‐36 (SF‐36) questionnaire to show statistically significant differences between groups in the domains of physical functioning in favour of the no specific therapy group and emotional role functioning in favour of the endovascular revascularisation group. </p> </section> <section id="CD010512-sec-0071"> <h5 class="title">Procedure‐related complications</h5> <p>None of the three studies provided data on the number of complications following endovascular revascularisation. However, two studies reported that no major procedure‐related complications had occurred (<a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). </p> </section> <section id="CD010512-sec-0072"> <h5 class="title">Cardiovascular events</h5> <p>None of the included studies reported data on cardiovascular events during follow‐up.</p> </section> <section id="CD010512-sec-0073"> <h5 class="title">Non‐treadmill functional performance measures</h5> <p>Two studies reported non‐treadmill functional performance measures (<a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a> reported on self‐reported walking distance and number of participants with at least 1 kilometre reported walking distance. At two years' follow‐up for both outcome measures, study authors reported no statistically significant differences between groups (P ≥ 0.70). After two years' follow‐up, <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a> reported a higher visual analogue scale (VAS) score (functional status) following endovascular compared with no therapy. </p> </section> <section id="CD010512-sec-0074"> <h5 class="title">Mortality</h5> <p>Three studies reported data on all‐cause mortality (<a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0008" title="NylaendeM , AbdelnoorM , StrandenE , MorkenB , SandbaekG , RisumO , et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) ‐ the 2‐years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery2007;33(1):3‐12. [PUBMED: 17055756] NylaendeM , KroeseAJ , MorkenB , StrandenE , SandbaekG , LindahlAK , et al. Beneficial effects of 1‐year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England)2007;12(4):275‐83. [PUBMED: 18048463] ">Nylaende 2007</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>). During follow‐up, 2 of 68 participants in the endovascular revascularisation group and 3 of 68 participants in the no therapy group had died (OR 0.75, 95% CI 0.13 to 4.44; P = 0.75) (<a href="./references#CD010512-fig-0011" title="">Analysis 1.6</a>). There was little heterogeneity (I² = 0%). </p> </section> <section id="CD010512-sec-0075"> <h5 class="title">Subgroup analysis</h5> <p>Given the limited number of studies, we performed no subgroup analysis.</p> </section> <section id="CD010512-sec-0076"> <h5 class="title">Sensitivity analysis</h5> <p>Given the limited number of studies, we performed no sensitivity analysis.</p> </section> </section> <section id="CD010512-sec-0077"> <h4 class="title">Comparison 2. Endovascular revascularisation versus conservative therapy</h4> <p>Data from five studies comparing endovascular revascularisation versus conservative therapy for intermittent claudication were eligible for inclusion, with a total sample size of 412 participants (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). The conservative therapy provided in these five studies was supervised exercise therapy. </p> <section id="CD010512-sec-0078"> <h5 class="title">Maximum walking distance</h5> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from five studies (n = 345) showed no clear differences in MWD between participants following endovascular revascularisation and those given supervised exercise therapy (SMD ‐0.42, 95% CI ‐0.87 to 0.04; P = 0.07; <a href="./references#CD010512-fig-0012" title="">Analysis 2.1</a>). Heterogeneity was substantial (I² = 69%). </p> <p>After long‐term follow‐up, use of a random‐effects model and pooled data from three studies (n = 184) showed no clear differences in MWD between participants following endovascular revascularisation and those given supervised exercise therapy (pooled SMD ‐0.02, 95% CI ‐0.36 to 0.32; P = 0.90; <a href="./references#CD010512-fig-0013" title="">Analysis 2.2</a>). There was little heterogeneity (I² = 24%). </p> </section> <section id="CD010512-sec-0079"> <h5 class="title">Pain‐free walking distance</h5> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from five studies (n = 345) showed no clear differences in PFWD between participants following endovascular revascularisation and those given supervised exercise therapy (SMD ‐0.05, 95% CI ‐0.38 to 0.29; P = 0.79; <a href="./references#CD010512-fig-0014" title="">Analysis 2.3</a>). Heterogeneity was substantial (I² = 53%). </p> <p>After long‐term follow‐up, use of a random‐effects model and pooled data from two studies (n = 147) showed no clear differences in PFWD between participants following endovascular revascularisation and those given supervised exercise therapy (pooled SMD 0.11, 95% CI ‐0.26 to 0.48; P = 0.54; <a href="./references#CD010512-fig-0015" title="">Analysis 2.4</a>). There was little heterogeneity (I² = 22%). </p> <p><a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a> also assessed long‐term PFWD (after 6 years' follow‐up) but provided no data on PFWD except for the statement that data showed no significant differences between groups over the long term. </p> </section> <section id="CD010512-sec-0080"> <h5 class="title">Secondary invasive interventions</h5> <p>Four studies reported data on the number of secondary invasive interventions during follow‐up (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). During 6 to 18 months' follow‐up, a secondary invasive intervention was performed in 22 of 201 participants in the endovascular revascularisation group, and in 16 of 194 participants in the supervised exercise therapy group (OR 1.40, 95% CI 0.70 to 2.80; P = 0.33). There was little heterogeneity (I² = 0%) (<a href="./references#CD010512-fig-0016" title="">Analysis 2.5</a>). </p> <p>Two studies reported data on the number of secondary invasive interventions during long‐term follow‐up (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). In <a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>, after six years' follow‐up, 8 of 30 participants in the endovascular revascularisation group and 9 of 30 participants in the control group needed a secondary invasive revascularisation procedure. In <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>, after seven years' follow‐up, 17 of 75 participants in the endovascular revascularisation group and 32 of 75 participants in the control group needed a secondary revascularisation procedure. </p> </section> <section id="CD010512-sec-0081"> <h5 class="title">Quality of life</h5> <p>Three studies assessed and reported disease‐specific QoL. <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> and <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a> used the VascuQol questionnaire, and <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> used the Peripheral Artery Questionnaire (PAQ). Pooled data from these studies (n = 301) produced a pooled SMD of 0.18 (95% CI ‐0.04 to 0.41; P = 0.11) showing no clear differences between study groups. There was little heterogeneity (I² = 0%) (<a href="./references#CD010512-fig-0017" title="">Analysis 2.6</a>). </p> <p>Three studies assessed and reported general health‐related QoL. <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> and <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a> used one or more domains of Short Form‐36, and <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> used Short Form‐12. We have provided a summary of their findings in <a href="#CD010512-fig-0004">Figure 4</a>. None of the domains showed a clear difference between study groups. </p> <div class="figure" id="CD010512-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Health‐related quality of life (mean differences between groups)." data-id="CD010512-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Health‐related quality of life (mean differences between groups).</p> </div> </div> </div> </section> <section id="CD010512-sec-0082"> <h5 class="title">Procedure related complications</h5> <p>Three studies provided data on the number of minor complications following endovascular revascularisation (<a href="#CD010512-tbl-0004">Table 1</a>) (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). <a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a> and <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> reported one arterial perforation during the procedure, which needed surgical revision. <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> stated that no major procedure‐related complications had occurred. </p> <div class="table" id="CD010512-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Minor complications following endovascular revascularisation</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Groin haematoma</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Artery dissection</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/106</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/106</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/67</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/52</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/75</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/75</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>nr: not reported.</p> </div> </div> </section> <section id="CD010512-sec-0083"> <h5 class="title">Cardiovascular events</h5> <p>No study reported data on cardiovascular events during follow‐up.</p> </section> <section id="CD010512-sec-0084"> <h5 class="title">Non‐treadmill functional performance measures</h5> <p>Two studies reported non‐treadmill functional performance measures including self‐reported walking distance, hourly free‐living steps measured with a pedometer, and functional status assessed with the walking impairment questionnaire (WIQ) and with PAQ (<a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>). <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> reported no clear differences in self‐reported walking distance between the two study groups at one year of follow‐up. After six months' follow‐up, <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> found no clear differences between study arms for change in hourly free‐living steps. Similarly in this study, at 18 months' follow‐up, PAQ and WIQ scores for all domains were comparable between groups, except for the PAQ physical limitation score and the PAQ summary score, both of which favoured the endovascular revascularisation group (P &lt; 0.05). </p> </section> <section id="CD010512-sec-0085"> <h5 class="title">Mortality</h5> <p>Five studies reported data on all‐cause mortality (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>; <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a>). During follow‐up, 11 of 222 participants in the endovascular revascularisation group and 12 of 213 participants in the supervised exercise therapy group had died (OR 0.84, 95% CI 0.35 to 2.00; P = 0.69). There was little heterogeneity (I² = 0%) (<a href="./references#CD010512-fig-0018" title="">Analysis 2.7</a>). </p> </section> <section id="CD010512-sec-0086"> <h5 class="title">Subgroup analysis</h5> <p>Given the limited number of studies and fact that conservative therapy in all studies consisted of supervised exercise therapy, we performed no subgroup analysis. </p> </section> <section id="CD010512-sec-0087"> <h5 class="title">Sensitivity analysis</h5> <p>In sensitivity analysis excluding <a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a> and <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>, which reported only median (IQR) MWD or PFWD; or <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>, which measured walking distances on a treadmill during only five minutes, which probably underestimated the treatment effect, results compared with the main analysis showed changes for the following outcome: At 6 to 12 months' follow‐up, pooled results for MWD from the three remaining studies (n = 232) ‐<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>, <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>, and <a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a> ‐ showed higher MWD in the supervised exercise therapy group than in the endovascular revascularisation group, with SMD of ‐0.52 (95% CI ‐0.98 to ‐0.07; P = 0.024) (<a href="./references#CD010512-fig-0019" title="">Analysis 2.8</a>). For all other outcomes, results from sensitivity analysis did not differ substantially from results obtained by the main analysis (<a href="./references#CD010512-fig-0020" title="">Analysis 2.9</a>). </p> <p>We did not perform sensitivity analysis on the methodological quality of studies or on individual study effects owing to the limited number of included studies. </p> </section> </section> <section id="CD010512-sec-0088"> <h4 class="title">Comparison 3. Endovascular revascularisation plus conservative therapy versus conservative therapy </h4> <p>Data from three studies (n = 457) ‐ <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>, <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>, and <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> ‐ comparing endovascular revascularisation plus supervised exercise versus supervised exercise alone and data from two studies (n = 199) ‐ <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> and <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> ‐ comparing endovascular revascularisation plus pharmacotherapy (i.e. cilostazol) versus pharmacotherapy for intermittent claudication were eligible for inclusion. </p> <section id="CD010512-sec-0089"> <h5 class="title">Maximum walking distance</h5> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from three studies (n = 432) showed no clear differences in MWD between participants following combination therapy versus supervised exercise therapy alone (SMD 0.26, 95% CI ‐0.13 to 0.64; P = 0.19; <a href="./references#CD010512-fig-0021" title="">Analysis 3.1</a>). Heterogeneity was substantial (I² = 70%). </p> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from two studies (n = 186) showed that participants following combination therapy had a higher MWD than those given pharmacotherapy alone (<a href="./references#CD010512-fig-0021" title="">Analysis 3.1</a>), with an SMD of 0.38 (95% CI 0.08 to 0.68; P = 0.014), which is equivalent to a small effect in favour of combination therapy. There was little heterogeneity (I² = 0%). </p> <p><a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a> provided long‐term data for MWD at two years' follow‐up for comparison of combination therapy versus supervised exercise therapy alone, which showed a higher MWD in the combination therapy group than in the supervised exercise therapy alone group (SMD 1.18, 95% CI 0.65 to 1.70; P &lt; 0.0001; 106 participants; <a href="./references#CD010512-fig-0022" title="">Analysis 3.2</a>). </p> <p><a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> provided long‐term data for MWD at 18 months' follow‐up for comparison of combination therapy versus pharmacotherapy alone, which showed a higher MWD in the combination therapy group than in the pharmacotherapy alone group (SMD 0.72, 95% CI 0.09 to 1.36; P = 0.02; 47 participants; <a href="./references#CD010512-fig-0022" title="">Analysis 3.2</a>). </p> </section> <section id="CD010512-sec-0090"> <h5 class="title">Pain‐free walking distance</h5> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from two studies (n = 305) showed no clear differences in PFWD between participants following combination therapy and those given supervised exercise therapy alone (pooled SMD 0.33, 95% CI ‐0.26 to 0.93; P = 0.27; <a href="./references#CD010512-fig-0023" title="">Analysis 3.3</a>). Heterogeneity was substantial (I² = 83%). </p> <p>After 6 to 12 months' follow‐up, use of a random‐effects model and pooled data from two studies (n = 186) showed that participants following the combination therapy had a higher PFWD than those given pharmacotherapy alone (<a href="./references#CD010512-fig-0023" title="">Analysis 3.3</a>), with SMD of 0.63 (95% CI 0.33 to 0.94; P &lt; 0.0001), which is equivalent to a moderate effect in favour of combination therapy. There was little heterogeneity (I² = 0%). </p> <p><a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a> compared combination therapy versus supervised exercise therapy alone in two separate trials ‐ the aortoiliac trial and the femoropopliteal trial ‐ and reported data on long‐term PFWD after two years' follow‐up. In the femoropopliteal trial, 63% of participants in the combination therapy group and 22% of those in the supervised exercise therapy group attained 200 metres without claudication pain, corresponding to an adjusted hazard ratio of 3.11 (95% CI 1.42 to 6.81; P &lt; 0.01) in favour of combination therapy. Similarly, in the aortoiliac trial, 61% of participants in the combination therapy group and 25% of those in the supervised exercise therapy group attained 200 metres without claudication pain, corresponding to an adjusted hazard ratio of 3.6 (95% CI 1.0 to 12.8; P = 0.05) in favour of combination therapy. </p> <p><a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> provided long‐term data for PFWD at 18 months' follow‐up comparing combination therapy versus pharmacotherapy alone showing no clear differences between study groups (SMD 0.54, 95% CI ‐0.08 to 1.17; P = 0.09; 47 participants; <a href="./references#CD010512-fig-0024" title="">Analysis 3.4</a>). </p> </section> <section id="CD010512-sec-0091"> <h5 class="title">Secondary invasive interventions</h5> <p>Three studies comparing combination therapy versus supervised exercise therapy alone reported data on the number of secondary invasive interventions during follow‐up (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>). During 12 to 24 months' follow‐up, investigators performed a secondary invasive intervention in 10 of 231 participants in the combination therapy group and in 37 of 226 participants in the supervised exercise therapy group (OR 0.27, 95% CI 0.13 to 0.55; P = 0.0003) (<a href="./references#CD010512-fig-0025" title="">Analysis 3.5</a>). There was little heterogeneity (I² = 0%). </p> <p>Two studies comparing combination therapy versus pharmacotherapy alone reported data on the number of secondary invasive interventions during follow‐up (<a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>). During 12 to 18 months' follow‐up, researchers performed a secondary invasive intervention in 10 of 98 participants in the combination therapy group and in 7 of 101 participants in the pharmacotherapy group (OR 1.83, 95% CI 0.49 to 6.83; P = 0.37) (<a href="./references#CD010512-fig-0025" title="">Analysis 3.5</a>). There was little heterogeneity (I² = 17%). </p> </section> <section id="CD010512-sec-0092"> <h5 class="title">Quality of life</h5> <p>Four studies assessed and reported disease‐specific QoL. <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>, <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>, and <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> used the VascuQol questionnaire, and <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> used the Peripheral Artery questionnaire. </p> <p>Pooled data from two studies (n = 330) comparing combination therapy versus supervised exercise therapy alone produced a pooled SMD of 0.25 (95% CI ‐0.05 to 0.56; P = 0.10) (<a href="./references#CD010512-fig-0026" title="">Analysis 3.6</a>) (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>). Heterogeneity was moderate (I² = 45%). </p> <p>Pooled data from two studies (n = 170) comparing combination therapy versus pharmacotherapy alone produced a pooled SMD of 0.59 (95% CI 0.27 to 0.91; P = 0.0003) (<a href="./references#CD010512-fig-0026" title="">Analysis 3.6</a>), which is equivalent to a small effect in favour of combination therapy (<a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>). There was little heterogeneity (I² = 0%). </p> <p>Five studies assessed and reported general health‐related QoL using one or more domains of Short Form‐36 or Short Form‐12 (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>). We have provided a summary of findings from these five studies in <a href="#CD010512-fig-0005">Figure 5</a>. For domains assessed on the physical functioning scale, the physical role scale, and the bodily pain scale, data show statistically significant differences in favour of combination therapy. </p> <div class="figure" id="CD010512-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Health‐related quality of life (mean differences between groups).A: Femoropoliteal trial.  B: Aortoiliac trial.1 In this study, the comparison was endovascular revascularisation plus supervised exercise versus supervised exercise.  2 In this study, the comparison was endovascular revascularisation plus pharmacotherapy with cilostazol versus cilostazol." data-id="CD010512-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Health‐related quality of life (mean differences between groups).</p> <p>A: Femoropoliteal trial.<br/> B: Aortoiliac trial. </p> <p><sup>1</sup> In this study, the comparison was endovascular revascularisation <i>plus</i> supervised exercise <i>versus</i> supervised exercise.<br/> <sup>2</sup> In this study, the comparison was endovascular revascularisation <i>plus</i> pharmacotherapy with cilostazol <i>versus</i> cilostazol. </p> </div> </div> </div> </section> <section id="CD010512-sec-0093"> <h5 class="title">Procedure related complications</h5> <p>Four studies provided data on the number of minor complications (<a href="#CD010512-tbl-0004">Table 1</a>) following endovascular revascularisation (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>). <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> reported one arterial perforation during the procedure, which needed a surgical revision. <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> reported an emergency surgical exploration due to access site bleeding. <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> stated that no major procedure‐related complications had occurred. </p> </section> <section id="CD010512-sec-0094"> <h5 class="title">Cardiovascular events</h5> <p>No study reported data on cardiovascular events during follow‐up.</p> </section> <section id="CD010512-sec-0095"> <h5 class="title">Non‐treadmill functional performance measures</h5> <p>Three studies reported non‐treadmill functional performance measures including self‐reported walking distance, hourly free‐living steps measured with a pedometer, and functional status assessed with WIQ and PAQ (<a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>). At one year of follow‐up, <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> reported no statistically significant difference in self‐reported walking distance between study groups, and <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> reported a significant difference in self‐reported MWD in favour of combination therapy over pharmacotherapy alone (P &lt; 0.01). After six months' follow‐up, <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> reported no statistically significant differences between groups for change in hourly free‐living steps. At 18 months' follow‐up, <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a> reported that for all domains of WIQ and PAQ summary score, a statistically significant greater improvement favoured combination therapy (P &lt; 0.05) over pharmacotherapy alone. </p> </section> <section id="CD010512-sec-0096"> <h5 class="title">Mortality</h5> <p>Three studies comparing combination therapy versus supervised exercise therapy reported data on all‐cause mortality showing that 5 of 231 participants in the combination therapy group and 7 of 226 participants in the supervised exercise therapy alone group had died (OR 0.67, 95% CI 0.20 to 2.21; P = 0.51) (<a href="./references#CD010512-fig-0027" title="">Analysis 3.7</a>) (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>). There was little heterogeneity (I² = 0%). </p> <p>Two studies comparing combination therapy versus pharmacotherapy reported data on all‐cause mortality showing that 5 of 99 participants in the combination therapy group and 1 of 102 participants in the pharmacotherapy alone group had died (OR 1.30, 95% CI 0.14 to 11.92; P = 0.82) (<a href="./references#CD010512-fig-0027" title="">Analysis 3.7</a>) (<a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>). There was little heterogeneity (I² = 8%). </p> </section> <section id="CD010512-sec-0097"> <h5 class="title">Subgroup analysis</h5> <p>Given the limited number of studies, we performed no subgroup analysis.</p> </section> <section id="CD010512-sec-0098"> <h5 class="title">Sensitivity analysis</h5> <p>In sensitivity analysis excluding <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>, which reported only median (IQR) MWD or PFWD and measured walking distances on a treadmill during only five minutes (probably underestimating the treatment effect), results compared with those of the main analysis showed changes in the following outcome: For the comparison of endovascular revascularisation plus supervised exercise versus supervised exercise alone, pooled results for MWD from the two remaining studies (n = 339) showed higher MWD in the combination therapy group than in the supervised exercise alone group, with SMD of 0.43 (95% CI 0.21 to 0.65; P &lt; 0.0001) (<a href="./references#CD010512-fig-0028" title="">Analysis 3.8</a>), which is equivalent to a moderate effect in favour of combination therapy (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>). For PFWD, results from <a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a> showed higher PFWD in the combination therapy group than in the supervised exercise alone group (SMD 0.62, 95% CI 0.34 to 0.89; P = 0.0001; 212 participants) (<a href="./references#CD010512-fig-0029" title="">Analysis 3.9</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010512-sec-0099" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010512-sec-0099"></div> <p>In this review, we included ten RCTs with a total of 1087 participants assessing the (added) effect of endovascular revascularisation in the management of patients with stable intermittent claudication. It should be stated that overall the studies included are relatively small and show considerable heterogeneity in outcome assessment and outcome reporting; therefore trial results must be interpreted with caution. </p> <section id="CD010512-sec-0100"> <h3 class="title" id="CD010512-sec-0100">Summary of main results</h3> <p>After comparing endovascular revascularisation versus no therapy (except exercise advice) for intermittent claudication, three studies (n = 134) provided data showing a moderate to large effect on walking distances in favour of endovascular revascularisation in the short term up to 12 months. However, after long‐term follow‐up, this short‐term advantage of endovascular revascularisation was uncertain upon pooling of results from two studies. In addition, as reported in these two studies, quality of life (QoL) and the number of secondary invasive interventions during follow‐up were not substantially different between study groups. </p> <p>After comparing endovascular revascularisation versus supervised exercise for intermittent claudication, five studies (n = 412) provided data showing no specific preference for one of the two treatment options. Overall, participants in the supervised exercise therapy group tended to have higher walking distances, and participants in the endovascular revascularisation group tended to have better general and disease‐specific QoL, yet these differences were not statistically significant. Similarly, the number of secondary invasive interventions during follow‐up was comparable between the two study groups. Sensitivity analysis excluding studies reporting only median walking distances and one study that measured walking distances on a treadmill during only five minutes, which probably underestimated the treatment effect, showed that participants following supervised exercise had a higher maximum walking distance (MWD) after 6 to 12 months when compared with participants following endovascular revascularisation. </p> <p>After comparing endovascular revascularisation plus conservative therapy versus conservative therapy alone for intermittent claudication, three studies (n = 457) comparing endovascular revascularisation plus supervised exercise versus supervised exercise alone provided data showing no clear difference in walking distances and in disease‐specific QoL between groups up to 12 months' follow‐up, and one study reported better walking distances in favour of combination therapy at 24 months' follow‐up. In addition, participants following endovascular revascularisation plus supervised exercise tended to have higher general health‐related QoL in favour of combination therapy for some of the Short Form (SF)‐36 domains. Finally, the number of secondary invasive interventions during follow‐up was significantly lower following combination therapy compared with supervised exercise alone. Sensitivity analysis excluding one study reporting only median walking distances and measuring walking distances on a treadmill during only five minutes, which probably underestimated the treatment effect, showed that participants following endovascular revascularisation plus supervised exercise had higher maximum walking distance (MWD) and pain‐free walking distance (PFWD) after 6 to 12 months compared with participants following supervised exercise only.<br/> <br/> When comparing endovascular revascularisation plus cilostazol versus cilostazol alone, two studies (n = 199) provided data showing a small to moderate effect on short‐ and long‐term walking distances in favour of combination therapy. In addition, participants following combination therapy had higher disease‐specific and general health‐related QoL with differences favouring endovascular revascularisation plus cilostazol for some of the SF‐36 domains. The number of secondary invasive interventions during follow‐up was not different between participants in the combination therapy group and those in the cilostazol only group. </p> <p>Six studies with a total of 366 participants randomised to an endovascular revascularisation procedure provided data on the number of procedure‐related complications. Overall endovascular revascularisation for claudication seems to be a relatively 'safe' procedure with an incidence of 8% (30/366) for minor procedure‐related complications (groin haematoma and artery dissection) requiring conservative management only. Three studies reported one arterial perforation each during the procedure that required a surgical revision. None of the studies reported any major procedure‐related complications leading to permanent disability or death. Yet, it should be noted that these data are based on complications within clinical studies, and complication rates in clinical practice might be much higher. </p> </section> <section id="CD010512-sec-0101"> <h3 class="title" id="CD010512-sec-0101">Overall completeness and applicability of evidence</h3> <p>In general, the ten included studies provided sufficient information on the predefined primary and secondary outcomes of this review, except for the number of cardiovascular events during follow‐up, which was not reported by any of the studies. </p> <p>Considerable heterogeneity in outcome assessment was evident between studies. The treadmill protocol (speed, grade, and time) used to assess primary outcome functional performance measures (i.e. MWD and PFWD) differed significantly between studies; therefore we used SMD as treatment effect for these outcomes to allow standardisation of study results to a uniform scale. In addition, some heterogeneity in outcome reporting was evident between studies, including three studies (<a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>) reporting only median (interquartile range (IQR)) MWD and PFWD. In sensitivity analysis excluding these studies and one study (<a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>) limiting treadmill time to assess MWD and PFWD to only five minutes, the main results changed significantly for three analyses as summarised above. </p> <p>Given the limited number of studies included in this review, we were unable to perform all of the predefined subgroup analyses to investigate existing clinical heterogeneity between studies based on the selected population (femoropopliteal vs aortoiliac vs combined disease) or heterogeneity due to the endovascular revascularisation procedure performed (angioplasty vs stenting). </p> <p>Given these restrictions, applicability of this review is limited to the general population of patients with intermittent claudication, and review findings do not allow robust conclusions for specific groups of participants or specific types of interventions given. </p> </section> <section id="CD010512-sec-0102"> <h3 class="title" id="CD010512-sec-0102">Quality of the evidence</h3> <p>We used GRADE criteria according to <a href="./references#CD010512-bbs2-0043" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a> and <a href="./references#CD010512-bbs2-0024" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐4. ">Atkins 2004</a> to assess the quality of evidence for the outcomes MWD, PFWD, secondary invasive interventions, and disease‐specific QoL. For each comparison, we created a summary of findings table by using GRADEpro software to summarise treatment effects and quality of evidence for each outcome. </p> <p>For the comparison endovascular revascularisation versus no specific therapy for intermittent claudication, we rated the quality of evidence as low (MWD and PFWD at long term) or moderate (MWD and PFWD at 6 to 12 months and secondary invasive interventions). We downgraded the quality of evidence for this comparison mainly because of small study sample sizes and the possibility of serious risk of bias in two studies with three or more risk of bias domains labelled as having 'unclear' risk (<a href="./full#CD010512-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>For the comparison endovascular revascularisation versus conservative therapy (i.e. supervised exercise), quality assessment ranged from moderate (MWD and PFWD at 6 to 12 months and at long term) to high (secondary invasive interventions and disease‐specific QoL). We downgraded the quality of evidence for this comparison mainly owing to substantial heterogeneity between studies and high risk of attrition bias in one of the five studies included in the analysis (<a href="./full#CD010512-tbl-0002">summary of findings Table 2</a>) (<a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a>). </p> <p>For the final comparison of combination therapy of endovascular revascularisation followed by conservative therapy versus conservative therapy alone, the quality assessment for the comparison combination therapy versus supervised exercise alone ranged from low (MWD at long term) to moderate (MWD and PFWD at 6 to 12 months and disease‐specific QoL) to high (number of secondary invasive interventions). We downgraded the quality of evidence for this comparison mainly owing to substantial heterogeneity between studies. We assessed quality for the comparison combination therapy versus pharmacotherapy alone as high (MWD and PFWD at 6 to 12 months, disease‐specific QoL, and number of secondary invasive interventions). </p> </section> <section id="CD010512-sec-0103"> <h3 class="title" id="CD010512-sec-0103">Potential biases in the review process</h3> <p>The Cochrane Vascular Information Specialist conducted a comprehensive search to identify all relevant studies for inclusion in this review. In addition, review authors handsearched the reference lists of all eligible studies and reviews for additional relevant studies. Nevertheless, unpublished studies or data may have been missed. We had to exclude two eligible studies because <a href="./references#CD010512-bbs2-0014" title="GelinJ , JivegardL , TaftC , KarlssonJ , SullivanM , DahllofAG , et al. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements. European Journal of Vascular and Endovascular Surgery2001;22(2):107‐13. [PUBMED: 11472042] ">Gelin 2001</a> reported no outcome measures for the subgroup of participants receiving endovascular revascularisation, and <a href="./references#CD010512-bbs2-0019" title="ThomsonIA , vanRijAM , MorrisonND , PackerSGK , ChristieR . A ten year randomised controlled trial of percutaneous femoropopliteal angioplasty for claudication. Australia and New Zealand Journal of Surgery1999; Vol. 69, issue Suppl:98. ">Thomson 1999</a> published only abstract data with incomplete results. We attempted to contact study authors to ask for relevant data but received no response. Study authors from <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> provided data on the subgroup of participants receiving endovascular revascularisation, which allowed us to include this study in the quantitative analysis. However, it should be noted that this study was not powered to detect a difference in outcomes between the subgroup of participants receiving endovascular revascularisation and control group participants. </p> <p>A potential bias that deserves attention is the limitation of maximum walking time on a treadmill test for assessment of the primary outcomes MWD and PFWD during follow‐up, which varied between studies and ranged from 5 minutes to 30 minutes. Particularly in studies such as <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>, which limited maximum walking time to only 5 minutes, and <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>, which limited walking time to 10 minutes, this may have caused serious underestimation of treatment effect, as participants might have been able to walk farther. This might explain the non‐significant differences between treatment groups as reported by these studies. In addition, to pool trial data, we assumed normal distribution for walking distances in three studies (<a href="./references#CD010512-bbs2-0004" title="HobbsSD , BradburyAW . The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery2006; Vol. 44, issue 2:432‐3. [PUBMED: 16890883] HobbsSD , MarshallT , FeganC , AdamDJ , BradburyAW . The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery2006;43(1):40‐6. [PUBMED: 16414385] ">Hobbs 2006</a>; <a href="./references#CD010512-bbs2-0005" title="LeeHLD , GulatiS , MehtaT , MekakoAI , RahmanMNA , McCollumP , et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain &amp; Ireland Yearbook. 2007:78. MazariFA , GulatiS , RahmanMN , LeeHL , MehtaTA , McCollumPT , et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery2010;24(1):69‐79. [PUBMED: 19762206] MazariFA , KhanJA , CarradiceD , SamuelN , Abdul RahmanMN , GulatiS , et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2012;99(1):39‐48. [PUBMED: 22021102] MazariFA , KhanJA , CarradiceD , SamuelN , GohilR , McCollumPT , et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery2013;100(9):1172‐9. [PUBMED: 23842831] ">Mazari 2011</a>; <a href="./references#CD010512-bbs2-0010" title="WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery1997;26(4):551‐7. [PUBMED: 9357454] WhymanMR , FowkesFG , KerracherEM , GillespieIN , LeeAJ , HousleyE , et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery1996;12(2):167‐72. [PUBMED: 8760978] ">Whyman 1996</a>) and used reported median values in the meta‐analysis; this may have biased pooled results. In sensitivity analysis excluding these studies, the main results changed significantly for three analyses, as summarised above. </p> </section> <section id="CD010512-sec-0104"> <h3 class="title" id="CD010512-sec-0104">Agreements and disagreements with other studies or reviews</h3> <p>Results of this review are in line with those of two previously published systematic reviews comparing treatment strategies for patients with intermittent claudication (<a href="./references#CD010512-bbs2-0022" title="AhimastosAA , PappasEP , ButtnerPG , WalkerPJ , KingwellBA , GolledgeJ . A meta‐analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. Journal of Vascular Surgery2011;54(5):1511‐21. [PUBMED: 21958561] ">Ahimastos 2011</a>; <a href="./references#CD010512-bbs2-0031" title="FransFA , BipatS , ReekersJA , LegemateDA , KoelemayMJ . Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. British Journal of Surgery2012;99(1):16‐28. [PUBMED: 21928409] ">Frans 2012</a>). Both reviews concluded that endovascular revascularisation alone provides no significant benefit over supervised exercise therapy alone, and combination therapy of endovascular revascularisation plus supervised exercise therapy may be superior to supervised exercise therapy alone. Since then, results from three sizeable RCTs have been published and are included in this review (<a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a>; <a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a>; <a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a>), overall confirming the conclusions provided by those two earlier systematic reviews. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010512-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010512-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010512-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010512-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Health‐related quality of life (mean differences between groups)." data-id="CD010512-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Health‐related quality of life (mean differences between groups).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Health‐related quality of life (mean differences between groups).A: Femoropoliteal trial.  B: Aortoiliac trial.1 In this study, the comparison was endovascular revascularisation plus supervised exercise versus supervised exercise.  2 In this study, the comparison was endovascular revascularisation plus pharmacotherapy with cilostazol versus cilostazol." data-id="CD010512-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Health‐related quality of life (mean differences between groups).</p> <p>A: Femoropoliteal trial.<br/> B: Aortoiliac trial. </p> <p><sup>1</sup> In this study, the comparison was endovascular revascularisation <i>plus</i> supervised exercise <i>versus</i> supervised exercise.<br/> <sup>2</sup> In this study, the comparison was endovascular revascularisation <i>plus</i> pharmacotherapy with cilostazol <i>versus</i> cilostazol. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 1 Maximum walking distance." data-id="CD010512-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 1 Maximum walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 2 Maximum walking distance (long‐term)." data-id="CD010512-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 2 Maximum walking distance (long‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 3 Pain‐free walking distance." data-id="CD010512-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 3 Pain‐free walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 4 Pain‐free walking distance (long‐term)." data-id="CD010512-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 4 Pain‐free walking distance (long‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 5 Secondary invasive interventions." data-id="CD010512-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 5 Secondary invasive interventions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 6 Mortality." data-id="CD010512-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Endovascular revascularisation versus no specific therapy except verbal advice to exercise, Outcome 6 Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 1 Maximum walking distance." data-id="CD010512-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 1 Maximum walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 2 Maximum walking distance (long‐term)." data-id="CD010512-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 2 Maximum walking distance (long‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 3 Pain‐free walking distance." data-id="CD010512-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 3 Pain‐free walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 4 Pain‐free walking distance (long‐term)." data-id="CD010512-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 4 Pain‐free walking distance (long‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 5 Secondary invasive interventions." data-id="CD010512-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 5 Secondary invasive interventions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 6 Quality of life (disease‐specific)." data-id="CD010512-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 6 Quality of life (disease‐specific). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 7 Mortality." data-id="CD010512-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 7 Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 8 Sensitivity analysis: maximum walking distance." data-id="CD010512-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 8 Sensitivity analysis: maximum walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 9 Sensitivity analysis: pain‐free walking distance." data-id="CD010512-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Endovasular revascularisation versus conservative therapy in form of supervised exercise, Outcome 9 Sensitivity analysis: pain‐free walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 1 Maximum walking distance." data-id="CD010512-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 1 Maximum walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 2 Maximum walking distance (long‐term)." data-id="CD010512-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 2 Maximum walking distance (long‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 3 Pain‐free walking distance." data-id="CD010512-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 3 Pain‐free walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 4 Pain‐free walking distance (long‐term)." data-id="CD010512-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 4 Pain‐free walking distance (long‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 5 Secondary invasive interventions." data-id="CD010512-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 5 Secondary invasive interventions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 6 Quality of life (disease‐specific)." data-id="CD010512-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 6 Quality of life (disease‐specific). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 7 Mortality." data-id="CD010512-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 7 Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 8 Sensitivity analysis: maximum walking distance." data-id="CD010512-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 8 Sensitivity analysis: maximum walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010512-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/urn:x-wiley:14651858:media:CD010512:CD010512-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_t/tCD010512-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 9 Sensitivity analysis: pain‐free walking distance." data-id="CD010512-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Endovascular revascularisation plus conservative therapy versus conservative therapy, Outcome 9 Sensitivity analysis: pain‐free walking distance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/media/CDSR/CD010512/image_n/nCD010512-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010512-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endovascular revascularisation compared with no specific therapy for intermittent claudication except verbal advice to exercise</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Endovascular revascularisation compared with no specific therapy for intermittent claudication except verbal advice to exercise </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> intermittent claudication<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> endovascular revascularisation<br/> <b>Comparison:</b> no specific therapy<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no specific therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endovascular revascularisation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.70 standard deviations higher (0.31 higher to 1.08 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximum walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean maximum walking distance at long term in the intervention group was 0.67 standard deviations higher (0.30 lower to 1.63 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 1.29 standard deviations higher (0.90 higher to 1.68 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean pain‐free walking distance at long term in the intervention group was 0.69 standard deviations higher (0.45 lower to 1.82 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.81<br/> (0.12 to 5.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>118<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>83 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>69 per 1000<br/> (11 to 324) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life (disease‐specific)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study reported no significant differences in disease‐specific QoL between study groups after 2 years without providing data </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). Pooled standardised mean differences were interpreted using rules of thumb (&lt; 0.40 = small, 0.40 to 0.70 = moderate, &gt; 0.70 = large effect) as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).<br/> CI: confidence interval; OR: odds ratio; QoL: quality of life; RCT: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Treatment consisted of cardiovascular risk factor management and only verbal exercise advice without any form of supervision.<br/> <sup>2</sup> In two studies, risk of bias on three or more domains judged as "unclear"; therefore quality of the evidence downgraded one level.<br/> <sup>3</sup> The possibility of publication bias could not be ruled out, yet we did not consider it sufficient to downgrade the quality of the evidence.<br/> <sup>4</sup> Small sample size with wide confidence interval for treatment effect; therefore quality of the evidence downgraded one level.<br/> <sup>5</sup> Evidence of inconsistency due to substantial heterogeneity between studies; therefore quality of the evidence downgraded one level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endovascular revascularisation compared with no specific therapy for intermittent claudication except verbal advice to exercise</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010512-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Endovascular revascularisation compared with conservative therapy for intermittent claudication</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Endovascular revascularisation compared with conservative therapy for intermittent claudication </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> intermittent claudication<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> endovascular revascularisation<br/> <b>Comparison:</b> conservative therapy (i.e. supervised exercise)<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conservative therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endovascular revascularisation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.42 standard deviations lower (0.87 lower to 0.04 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>345<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance at long term in the intervention group was 0.02 standard deviations lower (0.36 lower to 0.32 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 0.05 standard deviations lower (0.38 lower to 0.29 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>345<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance at long term in the intervention group was 0.11 standard deviations higher (0.26 lower to 0.48 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>147<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.40<br/> (0.7 to 2.8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>395<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>112 per 1000<br/> (59 to 201) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (disease‐specific)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean quality of life (disease‐specific) in the intervention group was 0.18 standard deviations higher (0.04 lower to 0.41 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>301<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). Pooled standardised mean differences were interpreted using rules of thumb (&lt; 0.40 = small, 0.40 to 0.70 = moderate, &gt; 0.70 = large effect), as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).<br/> CI: confidence interval; OR: odds ratio; RCT: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Supervised exercise consisted of only supervised exercise in four studies and a combination of supervised exercise and pharmacotherapy with cilostazol in one study.<br/> <sup>2</sup> Evidence of inconsistency due to substantial heterogeneity between studies; therefore quality of the evidence downgraded one level.<br/> <sup>3</sup> The possibility of publication bias could not be ruled out, yet we did not consider it sufficient to downgrade the quality of the evidence.<br/> <sup>4</sup> In one of three studies, risk of attrition bias judged as "high"; therefore quality of the evidence downgraded one level.<br/> <sup>5</sup> Small sample size with wide confidence interval for treatment effect; therefore quality of the evidence downgraded one level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Endovascular revascularisation compared with conservative therapy for intermittent claudication</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010512-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endovascular revascularisation plus conservative therapy compared with conservative therapy alone for intermittent claudication</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Endovascular revascularisation plus conservative therapy compared with conservative therapy alone for intermittent claudication </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> intermittent claudication<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> endovascular revascularisation plus conservative therapy (supervised exercise or pharmacotherapy with cilostazol)<br/> <b>Comparison:</b> conservative therapy (supervised exercise or pharmacotherapy with cilostazol)<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conservative therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endovascular revascularisation plus conservative therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Conservative therapy consists of supervised exercise</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.26 standard deviations higher (0.13 lower to 0.64 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>432<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance at long term in the intervention group was 1.18 standard deviations higher (0.65 higher to 1.70 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 0.33 standard deviations higher (0.26 lower to 0.93 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>305<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the studies reported any quantitative data on pain‐free walking distance at long term </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.27<br/> (0.13 to 0.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>457<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>164 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/> (25 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (disease‐specific)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean quality of life (disease‐specific) in the intervention group was 0.25 standard deviations higher (0.05 lower to 0.56 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>330<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Conservative therapy consists of pharmacotherapy (cilostazol)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance in the intervention group was 0.38 standard deviations higher (0.08 higher to 0.68 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean maximum walking distance at long term in the intervention group was 0.72 standard deviations higher (0.09 higher to 1.36 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only 1 small RCT included in this analysis, no meaningful grading of quality of evidence possible </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance in the intervention group was 0.63 standard deviations higher (0.33 higher to 0.94 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain‐free walking distance (long‐term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain‐free walking distance at long‐term in the intervention group was 0.54 standard deviations higher (0.08 lower to 1.17 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only one small RCT included in this analysis, no meaningful grading of quality of evidence possible </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Secondary invasive interventions</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.83<br/> (0.49 to 6.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>199<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/> (35 to 337) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (disease‐specific)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean quality of life (disease‐specific) in the intervention group was 0.59 standard deviations higher (0.27 higher to 0.91 higher). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). Pooled standardised mean differences were interpreted using rules of thumb (&lt; 0.40 = small, 0.40 to 0.70 = moderate, &gt; 0.70 = large effect), as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010512-bbs2-0035" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).<br/> CI: confidence interval; OR: odds ratio; RCT: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Conservative therapy consisted of supervised exercise in three studies and of pharmacotherapy with cilostazol and only advice to exercise in two studies.<br/> <sup>2</sup> The possibility of publication bias could not be ruled out, yet we did not consider it sufficient to downgrade the quality of the evidence.<br/> <sup>3</sup> Evidence of inconsistency due to substantial heterogeneity between studies; therefore quality of the evidence downgraded one level.<br/> <sup>4</sup> Small sample size with wide confidence interval for treatment effect; therefore quality of the evidence downgraded one level.<br/> <sup>5</sup> In this study risk of bias on three domains judged as "unclear"; therefore quality of the evidence downgraded one level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endovascular revascularisation plus conservative therapy compared with conservative therapy alone for intermittent claudication</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010512-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Minor complications following endovascular revascularisation</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Groin haematoma</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Artery dissection</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0001" title='CreasyTS , McMillanPJ , FletcherEW , CollinJ , MorrisPJ . Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery1990;4(2):135‐40. [PUBMED: 2140987] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery1996;11(4):409‐13. [PUBMED: 8846172] PerkinsJM , CollinJ , CreasyTS , FletcherEW , MorrisPJ . Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery2011;42(Suppl 1):S41‐5. [PUBMED: 21855020] '>Creasy 1990</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0002" title="FakhryF . Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation2013; Vol. 128, issue 24:2709‐10. FakhryF , SpronkS , van derLaanL , WeverJJ , TeijinkJA , HoffmannWH , et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA2015;314(18):1936‐44. [PUBMED: 26547465] ">Fakhry 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/106</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/106</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0003" title="GreenhalghRM , BelchJJ , BrownLC , GainesPA , GaoL , ReiseJA , et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery2008;36(6):680‐8. ">Greenhalgh 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/67</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0006" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER3rd , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology2015;65(10):999‐1009. [PUBMED: 25766947] MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six‐month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation2012;125(1):130‐9. MurphyTP , HirschAT , RicottaJJ , CutlipDE , MohlerE , RegensteinerJG , et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery2008;47(6):1356‐63. ReynoldsMR , ApruzzeseP , GalperBZ , MurphyTP , HirschAT , CutlipDE , et al. Cost‐effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association2014;3(6):e001233. [PUBMED: 25389284] ">Murphy 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0007" title="NordanstigJ , TaftC , HensaterM , PerlanderA , OsterbergK , JivegardL . Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one‐year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation2014;130(12):939‐47. [PUBMED: 25095886] ">Nordanstig 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/52</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010512-bbs2-0009" title="FakhryF , RouwetEV , denHoedPT , HuninkMG , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery2013;100(9):1164‐71. [PUBMED: 23842830] FakhryF , RouwetEV , denHoedPT , HuninkMGM , SpronkS . Long‐term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation2012;126(21 Suppl 1):Abstract 13102. SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Cost‐effectiveness of endovascular revascularization compared to supervised hospital‐based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery2008;48(6):1472‐80. [PUBMED: 18771879] SpronkS , BoschJL , denHoedPT , VeenHF , PattynamaPM , HuninkMG . Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital‐based exercise training ‐ randomized controlled trial. Radiology2009;250(2):586‐95. [PUBMED: 19188327] ">Spronk 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/75</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/75</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>nr: not reported.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Minor complications following endovascular revascularisation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/full#CD010512-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010512-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endovascular revascularisation versus no specific therapy except verbal advice to exercise</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maximum walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.31, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maximum walking distance (long‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [‐0.30, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain‐free walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.90, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain‐free walking distance (long‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [‐0.45, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Secondary invasive interventions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.12, 5.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.13, 4.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endovascular revascularisation versus no specific therapy except verbal advice to exercise</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010512-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Endovasular revascularisation versus conservative therapy in form of supervised exercise</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maximum walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.87, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maximum walking distance (long‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.36, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain‐free walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.38, 0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain‐free walking distance (long‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.26, 0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Secondary invasive interventions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.70, 2.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Quality of life (disease‐specific) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [‐0.04, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.35, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Sensitivity analysis: maximum walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐0.98, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Sensitivity analysis: pain‐free walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.46, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Endovasular revascularisation versus conservative therapy in form of supervised exercise</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010512-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Endovascular revascularisation plus conservative therapy versus conservative therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maximum walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐0.13, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maximum walking distance (long‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.65, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.09, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain‐free walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [‐0.26, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.33, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain‐free walking distance (long‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [‐0.08, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Secondary invasive interventions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.13, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [0.49, 6.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Quality of life (disease‐specific) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.05, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.27, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.20, 2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.14, 11.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Sensitivity analysis: maximum walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.21, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Sensitivity analysis: pain‐free walking distance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Supervised exercise therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.34, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.33, 0.94]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Endovascular revascularisation plus conservative therapy versus conservative therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010512.pub2/references#CD010512-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010512.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010512-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010512-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010512-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD010512-note-0001">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010512\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010512\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010512\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010512\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010512\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010512.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010512.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010512.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010512.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010512.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718711264"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010512.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718711268"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010512.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd702ee51f47a',t:'MTc0MDcxODcxMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 